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Background: Genetic and environmental factors have a varying infl uence on oral 
health-related problems. Although studies have been conducted, the contribution 
of genetic factors to sleep-related bruxism remains obscure. Bruxism causes several 
physical problems, including abnormal tooth wear, pain in the temporomandibular 
joint or jaw muscles, and headaches, as well as social problems. The detailed aetiology 
of bruxism is unknown. In addition to genetic factors, psychoactive substances are 
considered to be potential risk factors for bruxism. 
Aims: The aim of the present study was to explore the role of genetic and 
environmental factors in the phenotypic variance of self-reported sleep-related 
bruxism. A second aim was to investigate the potentially independent roles of three 
commonly used legal psychoactive substances, tobacco, alcohol, and coffee, in the 
occurrence of self-reported sleep-related bruxism. 
Subjects: The study was based on two large twin cohorts, one of young adults 
and the other of middle-aged twins. The data of young adult twins were derived 
from the fourth wave of the longitudinal FinnTwin16 cohort study consisting of 
twins born in 1975–1979. The participants (n=3124 subjects, mean age 24 years) 
completed a questionnaire in 2000–2002 enquiring about the, the occurrence of 
sleep-related bruxism in young adults and the use of tobacco products. The data of 
middle-aged adult twins derived from the Finnish Twin Cohort study consisting of 
twins born in 1930–1957. The participants (n=12 502 subjects, mean age 44 years) 
completed a questionnaire in 1990 enquiring about sleep-related bruxism and the 
use of psychoactive substances, tobacco products, alcohol, and coffee. 
Methods: Quantitative genetic modelling was based on the genetic similarity of 
monozygotic and dizygotic twins and on the decomposition of phenotypic variance 
into the following components: additive genetic effects (A), dominant genetic effects 
(D), and non-shared environmental effects (E). Quantitative genetic modelling was 
used to evaluate the relative proportion of genetic factors of the phenotypic variance 
in the liability to bruxism. Multinomial logistic regression was used to explore the 
association between bruxism and psychoactive substances as independent risk 
factors. 
Results: The models revealed a clear genetic component behind bruxism. The best 
fi tting genetic model for bruxism was the AE-model in which additive genetic effects 
6accounted for 52% of the total phenotypic variance with no gender differences. 
The three legal psychoactive substances (tobacco, alcohol, and coffee) were clearly 
associated with bruxism. In addition, all of them raised the odds for bruxism 
independently, and there were no signifi cant interactions between them. 
Conclusions: Genetic factors contribute to inter-individual differences and 
account for a substantial proportion of the phenotypic variation of the liability to 
sleep-related bruxism. Bruxism has no gender difference in its genetic architecture. 
Psychoactive substances are associated strongly with bruxism, and the relationship 
is independent of other psychoactive substances, cumulative, and dose-dependent. 
The twin approach provides evidence of a possible causal link between psychoactive 
substances and bruxism. Thus, this study consolidates new information about 
genetic and environmental factors in sleep-related bruxism.
7TIIVISTELMÄ
Tausta: Geneettiset tekijät ja ympäristötekijät vaikuttavat suuterveyteen liittyviin 
ongelmiin. Geneettisten tekijöiden merkitys unenaikaisessa bruksismissa on edel-
leen epävarma, vaikkakin tutkimuksia aiheesta on tehty. Bruksismi aiheuttaa useita 
fysiologisia ongelmia, kuten hampaiden kulumista, kipuja leukanivelten alueella 
ja puremalihaksissa sekä päänsärkyä. Lisäksi se saattaa aiheuttaa myös sosiaalisia 
ongelmia häiritessään kanssanukkujien yöunta. Bruksismin etiologia on yhä epä-
selvä. Bruksismialttiutta lisäävinä riskitekijöinä pidetään geneettisten tekijöiden 
lisäksi psykoaktiivisia aineita. 
Tavoitteet: Tutkimuksen tavoitteena on selvittää geneettisten tekijöiden ja ym-
päristötekijöiden merkitystä itseraportoidun unenaikaisen bruksismin fenotyyppi-
sessä varianssissa. Toisena tavoitteena on selvittää kolmen laillisen psykoaktiivi-
sen aineen, tupakan, alkoholin ja kahvin, merkitystä itseraportoidun unenaikaisen 
bruksismin itsenäisinä riskitekijöinä. 
Aineisto: Tutkimusaineisto koostuu kahdesta suuresta kaksoskohorttitutkimuk-
sesta, joista toinen käsittää nuoria aikuisia ja toinen keski-ikäisiä aikuisia. Nuorten 
aikuisten aineisto koostuu FinnTwin16 -pitkittäistutkimuksen neljännestä kyselys-
tä, johon osallistui vuosina 1975–1979 syntyneitä kaksospareja. Kaksoset (n=3124 
yksilöä, keski-ikä 24 vuotta) täyttivät vuosina 2000–2002 kyselylomakkeen, jossa 
oli kysymyksiä sekä unenaikaisesta bruksismista että tupakkatuotteiden käytöstä. 
Keski-ikäisten aikuisten aineisto koostuu Finnish Twin Cohort -tutkimuksesta, 
johon osallistui vuosina 1930–1957 syntyneitä kaksospareja. Kaksoset (n=12 502 
yksilöä, keski-ikä 44 vuotta) täyttivät vuonna 1990 kyselylomakkeen, jossa kysel-
tiin unenaikaisen bruksismin esiintymistä ja psykoaktiivisten aineiden, tupakan, 
alkoholin ja kahvin, käyttöä.
Metodit: Kvantitatiivinen geneettinen mallinnus perustuu identtisten ja epäi-
denttisten kaksosten geneettiseen samankaltaisuuteen. Malli jakaa fenotyyppisen 
varianssin kolmeen komponenttiin, jotka ovat additiiviset geneettiset tekijät (A), 
dominantit geneettiset tekijät (D) ja yksilölliset ympäristötekijät (E). Kvantitatiivista 
geneettistä mallinnusta käytetään tutkittaessa geneettisten tekijöiden ja ympäristö-
tekijöiden suhteellista osuutta yksilön bruksismialttiuden fenotyyppisessä vaihte-
lussa. Multinomiaalista logistista regressiota käytetään arvioimaan bruksismin ja 
psykoaktiivisten aineiden välistä yhteyttä ja psykoaktiivisten aineiden merkitystä 
bruksismin itsenäisinä riskitekijöinä. 
8Tulokset: Geneettiset tekijät selittivät selkeän osan bruksismialttiudesta. AE-malli 
osoittautui parhaaksi malliksi ja geneettiset tekijät selittivät mallissa 52% varians-
sista. Sukupuolten välillä ei esiintynyt eroja. Kaikki kolme tutkittua psykoaktiivista 
ainetta (tupakka, alkoholi ja kahvi) liittyivät merkitsevästi bruksismiin. Psykoaktii-
viset aineet eivät muodostaneet keskenään interaktioita, vaan psykoaktiiviset aineet 
toimivat itsenäisinä riskitekijöinä. 
Johtopäätökset: Geneettiset tekijät vaikuttavat merkittävästi yksilöiden välisiin 
eroavaisuuksiin unenaikaisessa bruksismialttiudessa ja selittävät siitä merkittävän 
osan. Geneettisten tekijöiden osuus vaihtelussa on riippumaton sukupuolesta. Psy-
koaktiivisilla aineilla on tärkeä merkitys bruksismin riskitekijöinä ja niiden yhteys 
bruksismiin on kumulatiivinen, annosriippuvainen ja toisista psykoaktiivisista ai-
neista riippumaton. Kaksostutkimusasetelma tukee psykoaktiivisten aineiden ja 
bruksismin välistä mahdollista kausaalisuhdetta. Tutkimus vahvistaa ja tuo esiin 
uutta informaatiota geneettisten tekijöiden ja ympäristötekijöiden merkityksestä 
unenaikaisessa bruksismissa.
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Bruxism is defi ned as teeth grinding and/or clenching during sleep or while awake 
(American Academy of Sleep Medicine 2005). It is classifi ed as a sleep-related 
movement disorder linked to micro-arousals of sleep (Macaluso et al. 1998, De 
Laat & Macaluso 2002, Lavigne et al. 2003). It causes several problems, including 
abnormal tooth wear, pain in the temporomandibular joint or jaw muscles, 
headaches, and even social problems (Kato et al. 2001, Lavigne, Manzini & Kato 
2005), which makes it a signifi cant concern for many people. The aetiology of 
bruxism remains partly unknown, although many theories exist. Initially, peripheral 
theories about the morphological factors causing bruxism governed, but nowadays 
theories about central regulation of pathophysiological or psychological mechanism 
dominate (Lavigne et al. 2008, Van der Zaag et al. 2008). Like most other traits, 
the liability to bruxism is probably affected by both genetic and environmental 
factors. Generally, the risk factors of bruxism are considered to be disorders in 
the dopaminergic system, stress, sleep disturbances, psychoactive substances like 
smoking, alcohol, and coffee, age, gender, and genetics (Hublin et al. 1998, Lavigne 
& Manzini 2000, Lavigne et al. 2001, Ohayon, Li & Guilleminault 2001, Chen et al. 
2005, Lobbezoo, Van Der Zaag & Naeije 2006, Lavigne et al. 2008).
Although the underlying mechanisms of the aetiology of bruxism are unknown, 
psychoactive substances, among others, are considered to be risk factors for bruxism 
(Lobbezoo & Naeije 2001, Ohayon, Li & Guilleminault 2001, Lavigne, Manzini & 
Kato 2005, Lobbezoo, Van Der Zaag & Naeije 2006). Psychoactive substances are 
substances that affect the central nervous system in a variety of ways and cause 
several changes to cognitive behaviour (World Health Organization 2004). The role 
of tobacco, alcohol, and coffee in bruxism has been studied, but the results have been 
controversial (Hartmann 1979, Hartmann et al. 1987, Bastien, Gale & Mohl 1990, 
Lavigne et al. 1997, Molina et al. 2001, Ohayon, Li & Guilleminault 2001, Johansson 
et al. 2004, Ahlberg et al. 2004, Ahlberg et al. 2005, Bellini et al. 2011, Kato et al. 
2012, Abe et al. 2012). Yet, because the dominating theory explaining bruxism is 
the central regulation (Lobbezoo & Naeije 2001), it is justifi ed to hypothesize that 
psychoactive substances affecting the brain have an impact on bruxism. While the 
use of medicinal psychoactive substances may confound the relationship between 
substances and bruxism because the medicated disease itself might affect bruxism, 
investigating these medicinal psychoactive substances are beyond the scope of this 
study. The use of illegal psychoactive substances, i.e. drugs, is also excluded because 
their use is likely to be enormously underreported. 
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1. INTRODUCTION
Genetic and environmental factors explain an individual’s phenotypic liability to 
bruxism (Hublin et al. 1998, Lavigne, Manzini & Kato 2005). However, evidence of 
genetic factors affecting bruxism is limited because of the small number of studies 
done in this area. Nevertheless, at least one study has shown genetic factors to play an 
important role in bruxism in adults (Hublin et al. 1998). Large-scale epidemiological 
studies are needed to elucidate the role of genetic factors. 
The present study focuses on the role of genetic and environmental factors and 
possible sex-specifi c genetic effects in the liability to bruxism by using a unique 
Finnish twin data. In addition to genetic effects, this study investigates three legal 
non-medicinal psychoactive substances, namely tobacco, alcohol, and coffee, as 
potential risk factors for bruxism.
15
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This review focuses on sleep-related bruxism and the use of psychoactive substances, 
namely tobacco, alcohol, and coffee, as well as on bruxism and genetic factors, 
heritability, and twin studies. The psychoactive substances are viewed in light of 
their association with bruxism. The focus on the use of tobacco and smokeless 
tobacco is shifted towards nicotine and nicotine dependence as important parts 
of tobacco use. Alcohol use is viewed as alcohol consumption, binge drinking, and 
passing out due to alcohol. Coffee use is viewed as total consumption of coffee and 
caffeine as a psychoactive substance. 
OVERVIEW OF ORAL HEALTH, GENETIC EPIDEMIOLOGY, AND PSYCHOACTIVE 
SUBSTANCE USE
Oral health is an important part of general health and has been widely studied 
(Petersen 2003). Variation in oral health is a unique mixture of genetic and 
environmental factors and gene-environment interactions. Twin studies are an 
excellent way to examine oral health-related issues. Based on epidemiological 
family and twin studies, some of the dental health variables have a strong genetic 
component, while others are more prone to environmental factors. A strong genetic 
component explains dental caries, tooth size and morphology, and dental arch 
dimensions (Boraas, Messer & Till 1988, Conry et al. 1993, Kabban et al. 2001, Shuler 
2001, Race, Townsend & Hughes 2006, Townsend et al. 2006). However, most 
studies of the genetic liability to dental diseases are based on rather moderate-sized 
samples, but the results are still statistically signifi cant. Dental caries, for instance, 
has been estimated to have a heritability of up to 70% in young twins aged under 
8 years, and genetic factors seem to affect inter-individual variation in children’s 
susceptibility to caries (Bretz et al. 2005, Bretz et al. 2006). However, not all dental 
health-related diseases and problems are genetically regulated. Especially diseases 
of the soft tissue, mainly the gums and parodontium (gingivitis and periodontitis), 
are generally thought to be caused by environmental factors such as lack of proper 
dental hygiene and content of oral fl ora (Michalowicz et al. 1991, Michalowicz et al. 
2000a). Moreover, no evidence of the heritability of temporomandibular disorders, 
TMD has been found (Michalowicz et al. 2000b). Still, a minor genetic component 
does not reveal everything about an individual’s liability to contract a disease. 
However, assessment of oral health is somewhat diffi cult using questionnaires 
alone. Interestingly, instead of using multi-item measures, the use of single-item 
16
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measures improves the validity in oral health studies (Locker 1996). Nevertheless, 
self-reported oral health fi ndings may differ from clinical fi ndings, but self-report 
has been shown to be useful at least in ascertaining the number of teeth and the 
presence of dentures, fi llings, root canal therapy, and fi xed and removable prostheses 
(Könönen, Lipasti & Murtomaa 1986, Palmqvist, Söderfeldt & Arnbjerg 1991, 
Pitiphat et al. 2002). However, self-report is less useful for identifying current 
dental caries and periodontal disease (Kallio 1996, Östberg, Halling & Lindblad. 
2003, Goodman et al. 2004). 
Overall, dentists see many oral health problems in addition to caries and gingivitis. 
Among others, these include periodontitis, oral cancers, temporomandibular 
disorders, and bruxism. It is important for dentists to deepen their understanding 
of the aetiology of these diseases, and thus, improve their prevention and treatment. 
Although all of these diseases do not act as general indicators of oral health, they are 
still relevant and uncomfortable problems for patients as well as cost-consuming for 
public dental care. Moreover, while each is an important separate research branch, it 
is common to all of them that specifi c genetic and environmental factors and gene-
environment interactions affect individuals’ phenotypic liability to them (Boraas, 
Messer & Till 1988, Michalowicz et al. 1991, Conry et al. 1993, Michalowicz et al. 
2000, Kabban et al. 2001, Shuler 2001, Race, Townsend & Hughes 2006, Townsend 
et al. 2006). Genetic epidemiology is a branch of research that can study them all. 
Genetic epidemiology investigates the role of the genetic basis of traits together 
with environmental factors and their potential interactions with genes in families 
and populations (Khoury, Beaty & Cohen 1993, Duncan 2004b). Because different 
environments can have different effects on people, genetic epidemiological studies 
are usually population-dependent and the results may differ widely in different 
populations. Moreover, some clusters of genes may be highly population-specifi c 
such that the importance of genetic factors varies between populations (Duncan 
2004b, Li et al. 2010). One way to study genetic epidemiology is to use twins. 
Twins share all or some of their segregating genes and by comparing twin pairs it is 
possible to estimate the relative proportion of genetic and environmental factors in 
the studied trait (Boomsma, Busjahn & Peltonen 2002, Duncan 2004a). However, 
twin design alone does not give information about the exact genes affecting the trait, 
and therefore, molecular epidemiology improves the study of genetic background. 
Molecular epidemiology, which examines the role of genetic and environmental 
factors at the molecular level, can be done by linkage studies or association studies 
(Duncan 2004b). At the moment, genome-wide association studies (GWAS) are the 
conventional approach, and they examine the common genetic variants and their 
relationship to a studied trait (Manolio 2010, Visscher et al. 2012). The present 
study apart from genetic epidemiology is a twin study, and twin studies in general 
as well as genetic modelling are reviewed later in this literature review.
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In addition to genetic factors, environmental factors are important and may 
have an even more prominent role in some diseases than genetic factors. Generally, 
environmental factors are any factors infl uencing individuals, regardless of their 
unique combinations of genes. Although the relevance of environmental factors 
varies, their role in individuals’ liability to any oral health problem is important. 
Depending on the studied trait, their share of the outcome varies (Boraas, Messer 
& Till 1988, Michalowicz et al. 1991, Conry et al. 1993, Kabban et al. 2001, Shuler 
2001, Race, Townsend & Hughes 2006, Townsend et al. 2006), but they always 
play some role. Therefore, environmental factors should also be investigated using 
epidemiological studies. One key environmental factor is psychoactive substances, 
which are widely used and also cause a variety of harmful health effects and costs 
to the health care sector (Rehm et al. 2007). The present study largely focuses 
on psychoactive substance use in addition to genetic factors. Below is a review of 
psychoactive substance and substance dependence.
Substances affecting the central nervous system, including the brain, are called 
neurochemicals. These can be divided into two groups: natural organic substances 
(mostly neurotransmitters) and other molecules (chemical substances or drugs). The 
natural organic neurotransmitters are released by neurons and they affect other cells, 
causing changes to the central nervous system. However, not every neurotransmitter 
is released naturally in every area. There are a variety of neurotransmitters, but 
the most common are monoamines (dopamine, norepinephrine, and serotonin), 
acetylcholine, glutamate, and GABA (γ-aminobutyric acid). The effects of 
neurotransmitters vary widely. For example, dopamine inhibits postsynaptic 
potentials, and its effects are linked to learning, motivation, and movement. It 
also plays an important role in general substance dependence as well as in nicotine 
and alcohol dependence. Norepinephrine, in turn, is involved in arousal and stress 
responses, while serotonin is related to regulation of mood, arousal, impulsivity, 
aggression, appetite, and anxiety. Serotonin is also involved in the effects of the 
central nervous system caused by nicotine, alcohol, and illicit drugs (cocaine and 
amphetamine). Acetylcholine plays an important role in the processes of learning 
and memory. It is also implicated in nicotine dependence and may even contribute 
to the effects of cocaine and amphetamine. Glutamate is important in learning as 
well, and it modulates neural responses to many psychoactive substances. GABA 
acts as an inhibitory neurotransmitter, and therefore, it directs the sedative and 
anxiety-reducing effects of alcohol, benzodiazepines, and barbiturates (World 
Health Organization 2004, Meyer & Quenzer 2004, Deutch & Roth 2003). 
While neurotransmitters are natural organic psychoactive substances, there 
are also a variety of substances affecting natural neurotransmitter release or the 
second messenger system. In addition, these substances have the ability to affect an 
individual’s perception, mood, thinking, and behavior by causing long-term changes 
18
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at the cellular level and further in complex physiological and behavioural changes in 
individuals’ consciousness, mood, motivation, and thinking processes (Koob 2003, 
World Health Organization 2004). These combined with learned positive physical 
or psychological signs form substance use dependence. Therefore, psychoactive 
substances fi rst reach the brain by absorbing into the brain from the blood plasma, 
thereafter binding to specifi c target sites (Meyer & Quenzer 2004). They then change 
the normally existing mechanism of the brain, causing substance use dependence 
after use (Koob 2003, Koob & Le Moal 2006). Substance dependence is often defi ned 
as follows: “When an individual persists in use of alcohol or other drugs despite 
problems related to use of the substance, substance dependence may be diagnosed. 
Compulsive and repetitive use may result in tolerance to the effect of the drug and 
withdrawal symptoms when use is reduced or stopped.” (American Psychiatric 
Association 1994). Nevertheless, there are several ways to diagnose substance use 
dependence. According to the ICD-10 classifi cation of mental and behavioural 
disorders (World Health Organization 1992), substance use dependence is examined 
with six criteria (including both physical and psychological symptoms); a diagnosis 
of “dependence” requires meeting at least three of these criteria. Alternatively, the 
Diagnostic and Statistical Manual (DSM-IV) (American Psychiatric Association 
1994), which is similar to the ICD-10, can be used.
Psychoactive substances are divided into four major classes according to their 
mode of action in the nervous system: stimulants (e.g. caffeine), which act as adenosine 
receptor antagonists, depressants (e.g. alcohol), which act as GABA receptor agonists 
and NMDA receptor antagonists, hallucinogens (e.g. LSD), and opioids (e.g. heroin) 
((Salaspuro, Kiianmaa & Seppä 2003, World Health Organization 2004). There 
are also substances, like the acetylcholine agonist nicotine, that can act as both 
stimulants and depressants depending on the dose (Henningfi eld, London & Pogun 
2009). Responses to these substances vary between individuals (Davidson, Finch 
& Schenk 1993), and not all individuals develop dependence (Goldstein & Kalant 
1990, Schuckit 2009). However, dependence on psychoactive substances is relatively 
common. One of the reasons why psychoactive substances are often used and the 
use is continued is to gain a physical or psychological experience of pleasure or 
to avoid pain or withdrawal symptoms (Koob 2003, World Health Organization 
2004). Further, psychoactive substances, despite their biological effects, can also 
be categorized into three groups according to their purpose of use and legality: 
medications, legal psychoactive substances, and illegal or illicit psychoactive 
substances. This literature review focuses on three commonly used legal, non-
medicinal psychoactive substances and their association with bruxism. These 
comprise nicotine as a component of tobacco products, ethanol as a component 




2.1.1. DEFINITION OF BRUXISM 
Bruxism is defi ned as “diurnal or nocturnal parafunctional activity that includes 
clenching, bracing, gnashing, and grinding of teeth” (American Academy of Sleep 
Medicine 2005). It is nowadays classifi ed as a sleep-related movement disorder 
that may involve both grinding and clenching associated with excessive (intense) 
micro-arousals (Macaluso et al. 1998, Kato et al. 2001, De Laat & Macaluso 2002, 
Lavigne et al. 2003, American Academy of Sleep Medicine 2005, Lavigne et al. 
2008). It may cause several problems, including abnormal tooth wear and fractures, 
failures of dental restorations, prostheses or implants, tooth mobility, and pain in 
the temporomandibular joint or jaw muscles, headaches, and even social problems 
(Kato et al. 2001, Lavigne, Manzini & Kato 2005). Still, not all bruxism necessarily 
causes notable problems, and the classifi cation between normal behavior and 
parafunctional type is challenging for researchers and clinicians.
Bruxism may also be divided into primary and secondary bruxism based on 
potential etiological factors (Lavigne, Manzini & Kato 2005). Primary bruxism is 
a basic phenomenon that is not affected by any medical condition or medication. 
Secondary bruxism, by contrast, is affected by a distinct medical condition, medication 
or other external substance. Overall, the amount of bruxism explained by primary 
or secondary factors is diffi cult to study because of the many confounding factors 
that are often present. Further, pure bruxism may be rare in the adult population.
Bruxism may also occur during waking hours and is then called awake bruxism. 
It is, contrary to sleep-related bruxism, most commonly manifested as tooth 
clenching associated with psychosocial factors (Lavigne et al. 2008, Manfredini & 
Lobbezoo 2009) and there is debate whether or not these two forms of bruxism are 
independent disorders (Manfredini & Lobbezoo 2010). This literature review and 
study, however, concentrates on sleep-related bruxism only and awake bruxism is 
left outside of the review of the literature.
2.1.2. EPIDEMIOLOGY OF BRUXISM 
The prevalence of bruxism varies among studies, but generally the prevalence of 
awake bruxism is thought to be about 20%, being more common among women, 
while the prevalence of sleep bruxism is about 8% in the adult population being 
same among sexes (Reding, Rubright & Zimmerman 1966, Glaros 1981, Lavigne 
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& Montplaisir 1994, Ohayon, Li & Guilleminault 2001, Lavigne, Manzini & Kato 
2005). However, based on self-report studies, the prevalence of bruxism is highest 
in children, gradually decreasing with increasing age; from 14–18% in childhood 
to 3% in the elderly (Lavigne & Montplaisir 1994, Laberge et al. 2000, Ohayon, 
Li & Guilleminault 2001, Ng et al. 2005). The importance of factors like ethnicity 
on the prevalence of bruxism is uncertain, (Lavigne & Montplaisir 1994, Laberge 
et al. 2000, Ohayon, Li & Guilleminault 2001, Lavigne, Manzini & Kato 2005, Ng 
et al. 2005).
2.1.3. DETECTING BRUXISM
Previously, based on the idea of peripheral regulation of bruxism, bruxism was 
mostly detected clinically by looking at attrition patterns, i.e. bruxofacets, of 
dentition. Nowadays, bruxism is detected by using questionnaires or interviews 
and/or clinical examinations, including also direct measurement techniques of 
sleep laboratories. This direct measurement based on electromyography (EMG) and 
polysomnography (PSG) allows accurate diagnosis of current bruxism (De Leeuw 
2008). However, the technique requires an experienced analyst due to diffi culties 
in observing differences between oromandibular movements of interest and other 
types of oromandibular activities (Lavigne et al. 2008). Further, the major problems 
with a sleep laboratory setting are the high price of the method, the time-consuming 
analyses, the possible disturbances of sleep created by an atypical environment, and 
the potential long distances between the sleep laboratory and the homes of study 
subjects (Lavigne, Rompre & Montplaisir 1996, Manfredini & Lobbezoo 2010). 
Therefore, the sleep laboratory setting is best-suited to studies with small sample 
sizes, and large-scale epidemiological studies mostly rely on self-reporting methods 
(Manfredini & Lobbezoo 2010). Despite these diffi culties, the best available method 
for detecting bruxism is the sleep laboratory setting because the main problem 
with self-reports is that not all individuals are aware of their bruxism, resulting in 
underreporting. However, based on the study of Rompré et al. (2007), over 74% 
of patients diagnosed with bruxism are aware of their condition. Therefore, self-
report is currently the best available method for large-scale epidemiological surveys.
2.1.4. AETIOLOGY OF BRUXISM
The aetiology of bruxism is partly unknown, although many studies have explored 
the risk factors and mechanisms underlying the genesis of bruxism. Overall, 
several factors explaining the aetiology of bruxism have been suggested, including 
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morphological, pathophysiological, and psychosocial factors (Lobbezoo, Van Der 
Zaag & Naeije 2006). Further, two different aetiological theories exist to explain 
the unsolved nature of bruxism. These are peripheral (morphological) and central 
(pathophysiological and psychological) (Lavigne et al. 2008). In the early days of 
bruxism research, morphological factors alongside “neurotic tensions” were thought 
to be mainly responsible for the initiation of bruxism (Ramfjord 1961, Lobbezoo & 
Naeije 2001). Especially different disharmonies of occlusion were believed to induce 
bruxism in an effort to eliminate the interferences in occlusion. Later studies have 
failed to prove any signifi cant association between morphological interferences and 
bruxism, any benefi t of occlusal adjustment in the treatment of bruxism or evidence 
of a causal relationship between bruxism and peripheral factors (Lobbezoo & Naeije 
2001, Lobbezoo, Van Der Zaag & Naeije 2006, Lobbezoo et al. 2012). 
Therefore, at present, the theory of central regulation overwhelms the theory of 
peripheral regulation (Lobbezoo & Naeije 2001, Lobbezoo, Van Der Zaag & Naeije 
2006). Nowadays, many pathophysiological and psychosocial factors seem to be 
related to bruxism. Also, age, gender, and genetic factors affect an individual’s 
liability to bruxism (Hublin et al. 1998, Bader & Lavigne 2000, Kato et al. 2012). The 
current theory of central regulation of bruxism refl ects the idea that certain aspects 
of central neurotransmitter systems, especially the dopaminergic system, may alter 
or initiate bruxism (Winocur et al. 2003, Lobbezoo, Van Der Zaag & Naeije 2006). 
Bruxism is associated with such pathophysiological factors as sleep disturbances 
and sleep apnea, disorders in dopaminergic system, refl ux disease, use of certain 
medications, illicit drugs, and legal psychoactive substances like tobacco, alcohol, 
and coffee (Bader & Lavigne 2000, Lavigne & Manzini 2000, Lobbezoo & Naeije 
2001, Ohayon, Li & Guilleminault 2001, Lavigne, Manzini & Kato 2005, Lobbezoo, 
Van Der Zaag & Naeije 2006). In addition, a role of certain medications in inducing, 
relieving, or worsening bruxism has been proposed, although evidence is weak 
because of small sample sizes or case-study aspects of these studies and because 
the disease being treated may itself affect bruxism (Winocur et al. 2003). Further 
investigations are warranted to elucidate the role of specifi c neurotransmitters and 
neurochemicals. 
Psychosocial factors, including stress, anxiety, depression, and other personality 
traits, have been proposed to affect both awake and sleep-related bruxism (Pingitore, 
Chrobak & Patrie 1991, Fischer & O’toole 1993, Ahlberg et al. 2002, Lobbezoo, Van 
Der Zaag & Naeije 2006, Ahlberg et al. 2008, Manfredini & Lobbezoo 2009, Ahlberg 
et al. 2013). However, there is still a lack of evidence of their role in sleep-related 
bruxism (Lobbezoo, Van Der Zaag & Naeije 2006, Manfredini & Lobbezoo 2009), 
although some evidence of their relationship especially with self-reported sleep-
related bruxism exist (Manfredini & Lobbezoo 2009). Ohayon et al. (2011) found 
that self-reported sleep-related bruxism associated signifi cantly with mood, anxiety, 
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adjustment disorders, and hallucinatory phenomena, while Winocur et al. (2011) 
found that higher levels of emotional stress was more common among those who 
reported sleep-related bruxism. Manfredini et al. (2005) instead studied clinically 
diagnosed bruxism and found some association between clinically diagnosed sleep-
related bruxism and certain psychopathological symptoms. Later, Manfredini et 
al. (2011) also reported that trait anxiety was related in the sleep-time masticatory 
muscle activity. 
Psychosocial factors and psychoactive substances are related to each other. 
Many psychoactive substances affect an individual’s perception, mood, thinking, 
and behavior (Koob 2003, World Health Organization 2004). Also, psychosocial 
factors may drive for the use of psychoactive substances (Patton et al. 1998, Sonntag 
et al. 2000) and therefore it remains unclear whether the role of psychosocial factors 
on bruxism is independent of the effect of psychoactive substances. Only, Ohayon 
et al. (2001) adjusted their models with multiple variables and in their results both 
psychosocial factors and psychoactive substances act as risk factors for bruxism. 
Therefore, further investigations of the possible link between psychosocial factors 
and psychoactive substances in the aetiology of bruxism are needed.
2.1.5. GENETIC FACTORS AFFECTING BRUXISM
Genetic factors affecting the genesis of bruxism or an individual’s liability to bruxism 
remain unknown. Only a few questionnaire-based or large-scale twin studies 
reporting some genetic background for bruxism exist (Hublin et al. 1998, Lavigne, 
Manzini & Kato 2005, Lavigne et al. 2008). Some studies have indicated a hereditary 
component for bruxism, although most of these studies have been performed with 
only a few individuals. Multiple genes may be linked to the genesis of bruxism, and 
the exact genes are diffi cult to identify (Lavigne et al. 2008).
The earliest reports of a hereditary component of bruxism are from the 1960s 
and 1970s (Horowitz 1963, Reding, Rubright & Zimmerman 1966, Abe & Shimakawa 
1966, Lindqvist 1974). These are based either on attrition patterns in dentition 
(Horowitz 1963, Lindqvist 1974) or on self-reports of sleep bruxism (Reding, 
Rubright & Zimmerman 1966, Abe & Shimakawa 1966). Both Horowitz (1963) and 
Lindqvist (1974) have studied twin pairs and found some evidence that monozygotic 
twins have higher concordance rates than dizygotic twins. In addition, Reding et 
al. (1966) studied individuals and their blood relatives and found a signifi cant 
association between their reported bruxism. Similarly, Abe and Shimakawa (1966) 
evaluated children and their parents and noted that those children whose parents 
suffered from sleep bruxism were also more likely to experience sleep bruxism. 
However, all of these studies are based on the idea that bruxism is peripherally 
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regulated, and some of the studies diagnosed bruxism according to attrition patterns 
in dentition.
Later, Hublin et al. (1998) performed a large twin cohort study using middle-
aged twins. They observed a strong association between bruxism in childhood 
and adulthood. They also found a notable hereditary component for the liability 
to bruxism in adulthood. The hereditary component differed among the sexes, 
with genetic factors explaining 39% of an individual’s liability to bruxism in males 
and 53% in females. The rest of the phenomenon was explained by non-shared 
environmental factors. However, they could not determine whether genes specifi c 
to one sex, sex-specifi c common environmental effects, or sex-specifi c additive 
genetic effects affect the variation in bruxism due to the lack of opposite-sex pairs 
for the sex-limitation model. Thus, there is a need for studies to investigate gender 
differences in the genetic liability to bruxism. 
Although genetic research on the genetic component and heredity of bruxism 
has been performed, only two studies on the molecular basis for bruxism exist 
(Nowakowska et al. 2010, Abe et al. 2012). Further, some suggestions about genetic 
markers for bruxism have been made, although these markers remain mainly 
unknown (Abe et al. 2012). Nowakowska et al. (2010) reported a case study of four 
young children with either deletions or mutations involving MEF2C in 5p14.3. They 
reported two of the four children to also suffer from bruxism. However, bruxism 
was not studied in further detail. Abe et al. (2012), on the other hand, analysed and 
genotyped 112 individuals for 13 polymorphisms in four genes related to serotonergic 
neurotransmission. According to their analyses, only the C allele carrier of HTR2A 
single-nucleotide polymorphism rs6313 was signifi cantly associated with sleep 
bruxism, indicating that the serotonergic system may play a role in the genesis of 
bruxism. However, further molecular genetic studies on bruxism are warranted.
2.1.6. PSYCHOACTIVE SUBSTANCES AS RISK FACTORS FOR BRUXISM 
Studies on the role of neurochemical substances exist (Winocur et al. 2003, Lobbezoo, 
Van Der Zaag & Naeije 2006), but the importance of these neurochemicals in the 
aetiology of bruxism is under debate. The relationship between neurotransmitters 
and bruxism is challenging to study, and no strong evidence has yet emerged of 
any single neurotransmitter, neurochemical mechanism, or a specifi c gene in the 
genesis of bruxism. Also the facts that most neurochemicals have several targets of 
action, neurotransmitters have several target receptors, and subtypes of receptors 
have many different types of action and also a high affi nity for other substances 
and receptors make studying their detailed role in bruxism diffi cult.
Most studies have concentrated on common legal drugs and the psychoactive 
substances of nicotine, alcohol, and coffee, while studies on illegal psychoactive 
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substances, such as opioids, cocaine, and amphetamine, are less common. All of 
these psychoactive substances change the levels of natural neurotransmitters in 
the central nervous system (World Health Organization 2004). Further, most of 
these psychoactive substances affect the dopaminergic system and therefore may, 
despite their large variation in physiological effects, infl uence the genesis of bruxism 
(Winocur et al. 2003). A more detailed review of the role of the psychoactive 
substances of nicotine, alcohol, and coffee is provided in Sections 2.1.5.1.–2.1.5.3.
2.1.6.1. Tobacco and bruxism 
Of the preventable causes of death, smoking remains a forerunner. Although 
smoking is decreasing in Western societies, it is increasing in developing countries. 
One-third of the adult population worldwide is estimated to smoke (Hammond 
2009). Furthermore, nicotine is among the most commonly used highly addictive 
agents around the world (World Health Organization 2004), and according to the 
World Health Organization (2006) “Cigarettes are among the most deadly and 
addictive products ever produced by mankind”. A large variety of tobacco products 
exist, including cigarettes, cigars, pipes, smokeless tobacco called oral snuff, water 
pipe tobacco, and biting tobacco (Hammond 2009). While smoking has decreased 
in Western societies over the past twenty years, it is still rather common (World 
Health Organization 2004, World Health Organization 2006). It is, however, more 
common among individuals in lower socio-economic groups, and the prevalence 
of smoking appears to decrease more slowly among these individuals (Giskes et 
al. 2005, Helakorpi et al. 2008). About 32% of the Finnish population smoked 
in 1990, while the corresponding proportion in 2010 was about 20% (Suomen 
virallinen tilasto 2005, Jääskeläinen 2011).) In addition, approximately 28% of 
the young adults (aged 15–24 years) smoked in 1990 (Suomen virallinen tilasto 
2005), whereas in 2010 the proportion was 18% (Helakorpi et al. 2011). Altogether, 
smoking was more common in men (aged 15–64 years) than in women in 2010 
(23% vs. 16%). However, 16-year-old girls smoke more than boys (22% vs. 21%). 
Of boys aged 15–24 years, 6% smoked occasionally; the corresponding proportion 
for girls was 8% (Jääskeläinen 2011). 
Tobacco products are noxious to the health; they cause untimely death and a 
variety of self-imposed diseases (Doll et al. 1994, Neubauer et al. 2006). They also 
increase work disability rate, shorten working age, and raise expenses incurred by 
society. They have a clear association with such oral health problems as increased 
risk for periodontal diseases (formation of pockets and loss of alveolar bone) (Walter, 
Kaye & Dietrich 2012), complications in the success of dental treatment (Levin, 
Schwartz-Arad 2005, Grossi et al. 2007, Heng et al. 2007), increased risk of oral 
cancers (Ram et al. 2011), discolouration of teeth (Alkhatib, Holt & Bedi 2005), and 
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even the sleep-related tooth grinding habit of bruxism (Lavigne et al. 1997, Molina 
et al. 2001, Ohayon, Li & Guilleminault 2001, Johansson et al. 2004, Ahlberg et 
al. 2004, Ahlberg et al. 2005, Kato et al. 2012, Abe et al. 2012). 
Tobacco leaves contain over 2500 chemical constituents, and smoke from 
cigarettes contains over 4000 different toxic chemical substances (Haustein 
& Groneberg 2010). Of these chemicals, nicotine remains the main substance 
underlying dependence. Nicotine derives from the leaves of tobacco plants, where 
it acts as a botanical insecticide (Benowitz, Hukkanen & Peyton 2009), and is highly 
toxic in its pure form. In cigarettes, the nicotine content is about 1.5% by weight, and 
the amount of nicotine is similar in the smokeless tobacco called oral snuff (Benowitz, 
Hukkanen & Peyton 2009). The initiation of the effects of nicotine depends on 
the type of tobacco product, but overall nicotine absorbs quickly into the blood 
circulation and binds to the nicotinic acetylcholine receptors in the brain, where it 
causes a variety of physiological and psychological effects (Benowitz, Hukkanen & 
Peyton 2009, Djordjevic, Doran 2009).
Nicotine acts as an agonist for several types of nicotinic acetylcholine receptors 
(nAChRs) (Koob 2003). It affects various neurotransmitter systems by modulating 
presynaptic neurotransmitter release, and it also promotes dopamine synthesis, 
stimulates its transmission, and changes the ganglionic potentials (Henningfi eld, 
Keenan & Clarke 1996, Role & Berg 1996, Meyer & Quenzer 2004, Li, Mao & 
Wei 2008, Henningfi eld, London & Pogun 2009). The physical effects of nicotine 
comprise increased pulse rate and blood pressure and the secretion of glucocorticoids 
and vasopressin (Pomerleau et al. 1983). Because of its effects on the dopamine 
system, it causes several dose-related behavioural and psychoactive effects, including 
arousal, pleasure, increased attention and concentration, enhanced memory, 
reward, and euphoria, reduction of anxiety, and suppression of appetite (Koob 2003, 
World Health Organization 2004). It also reduces stress, causes mood changes, 
enhances performance, and acts as a self-stimulator (Goldberg & Henningfi eld 1988, 
World Health Organization 2004). Further, high levels of nicotine in the brain and 
plasma cause a rewarding effect, thus rapidly leading to tolerance, withdrawal, and 
dependence. However, the rewarding effect quickly vanishes when the nicotinic 
receptors desensitize and nicotine metabolizes (World Health Organization 2004). 
This creates a loop when an individual smokes to maintain nicotine levels and tries 
to avoid the negative effects of withdrawal, thereby controlling mood (Koob 2003, 
World Health Organization 2004). Not everyone develops nicotine dependence, 
which is infl uenced by different genetic factors as well as environmental factors 
(Niu et al. 2000, Feng et al. 2004). Of current smokers, approximately 53–76% can 
be classifi ed as nicotine-dependent, depending on the test used, and twin studies 
have shown that genetic factors account for about 30–70% of the liability to develop 
nicotine dependence (True et al. 1997, Kendler et al. 1999, Lessov et al. 2004, Maes 
et al. 2004, Broms et al. 2006, Rose RJ. et al. 2009).
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Nicotine dependence can be assessed using several questionnaire-based 
tests, the most common being the Diagnostic and Statistical Manual of Mental 
Disorders, fourth edition (DSM-IV) (American Psychiatric Association 1994), and 
the Fagerström Test for Nicotine Dependence (FTND) (Heatherton et al. 1991, 
Fagerström & Furberg 2008). Both of these tests consist of multiple questions 
measuring physiological and psychological dependence. However, these tests 
differ in their approach to nicotine dependence. The DSM criteria focus on both 
components of nicotine dependence extensively, with the wider aspects of the 
behavioral pattern of compulsive substance use and psychological dimensions of 
addiction, while the FTND focuses more on the behavioral components and less on 
the physiological components of tolerance and withdrawal. Thus, the DSM criteria 
approach dependence from a more general viewpoint than the narrow viewpoint 
examined by the FTND. The DSM-IV is used in the present study. To reach a 
diagnosis of “dependence”, three of the seven criteria must be met within a 12-month 
period (presented later in section 4.2. nicotine dependence). 
The role of smoking in the aetiology of bruxism is rather unknown. To date, 
only eight studies have investigated the association between smoking and bruxism 
(Lavigne et al. 1997, Molina et al. 2001, Ohayon, Li & Guilleminault 2001, Johansson 
et al. 2004, Ahlberg et al. 2004, Ahlberg et al. 2005, Kato et al. 2012, Abe et al. 2012). 
These earlier studies differ largely in study design, sample size, defi nition of smoking, 
assessment of bruxism, and control of covariates (Table 1). All have used subject self-
reports of bruxism by questionnaire or by interview for the epidemiological analyses, 
while Lavigne et al. (1997), Johansson et al. (2004), Kato et al. (2012), and Abe 
et al. (2012) have done further analyses of bruxism (either clinical examination or 
sleep laboratory analyses). Although showing some degree of association between 
smoking and bruxism, none of these papers, with the exception of Abe et al. (2012), 
have looked at smoking in more detail, investigating, for instance, the amount 
smoked, the type of tobacco products used, or the role of former smoking. Instead 
they used a smoking versus non-smoking approach, providing evidence that smokers 
may be at a higher incidence of bruxism. In addition, the role of heavy smoking 
and nicotine dependence in the aetiology of bruxism is completely unexplored.
In the study of Lavigne et al. (1997) using questionnaires (n=2019) smokers 
reported more bruxism (OR 1.9) than non-smokers. They further studied a 
subsample of 15 individuals in the sleep laboratory and found smokers to have fi ve 
times more bruxism episodes during sleep than non-smokers. Molina et al. (2001) 
observed that the smoking habit increased with the severity of bruxism and that the 
control group smoked less than the bruxism group. Consistent with the fi ndings of 
Lavigne et al. (1997), Ohayon et al. (2001) using interviews (n=13057) revealed a 
higher odds of bruxism in smokers (OR 1.6), but after adjustment for covariates only 
light smokers had a signifi cantly higher odds (OR 1.3) for bruxism. Johansson et al. 
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(2004) also used questionnaires (n=6343) and clinical examinations (n=941) in their 
cross-sectional study with 50-year-old males and females and noted a signifi cant 
association between self-reported bruxism and daily tobacco use (either cigarette 
smoking or smokeless tobacco). Based on questionnaire and clinical examination, 
Kato et al. (2012) also found smoking to raise the risk of self-reported sleep bruxism 
almost twofold, OR 1.8. Similarly, Ahlberg et al. (2004) reported smokers (including 
all tobacco use: cigarettes, cigars, pipe, and smokeless tobacco) to be 2.4 (95% 
CI 1.2–4.9) times more likely than non-smokers to experience bruxism in a non-
patient population of a media company (n=211). By contrast, in another survey in 
the same company (n=874), smoking frequency and frequent bruxism were weakly, 
albeit not statistically signifi cantly associated (Ahlberg et al. 2005). Also Abe et al. 
(2012) in their questionnaire and sleep laboratory-based study failed to show any 
signifi cant association between the amount of daily smoked cigarettes and bruxism.
Summing up, most existing studies have found some association between 
smoking and bruxism although few studies have failed to provide evidence of the 
association. The odds for bruxism have varied being about 1.0–2.4 times higher in 
smokers than in non-smokers.
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2.1.6.2. Alcohol and bruxism
Alcoholic beverages have a long history worldwide, and evidence of the use of 
alcohol dates back thousands of years. Alcohol, which includes the psychoactive 
substance ethanol, is a legal substance, although its acquisition is restricted to 
persons over a certain minimum age in many countries (Hanson 1995). Alcohol 
is most commonly consumed in the form of various alcoholic beverages such as 
beer, wine, or spirits. Ethanol is quickly absorbed into the bloodstream and carried 
to brain. Alcoholic beverages are consumed for several different reasons: in social 
situations to refresh, relax, and provide courage and also for religious, medicinal, 
and analgesic use (World Health Organization 2004). Unfortunately, alcohol is also 
misused because of its effect on behaviour and mood and its addictive properties. 
The psychoactive properties of alcohol are in general dose-dependent, and excessive 
doses cause ataxia, blackouts, impaired reaction time, and sedation (World Health 
Organization 2004, Koob & Le Moal 2006). In addition, smoking often co-occurs 
with alcohol consumption (Grucza & Bierut 2006, Li et al. 2007). 
Alcohol use in general may be divided into different forms of use; e.g. alcohol 
consumption (light, moderate, heavy), binge drinking, or alcohol abuse. Alcohol 
portion is defi ned as the amount of pure ethanol so that a standard drink equals 14 
grams of pure ethanol, which as a drink is equal to 350 ml of beer, 150 ml of wine, 
or 44 ml (a ”shot”) of 80-proof distilled spirits or liquor. The defi nitions of alcohol 
consumption vary greatly between studies (Leeman et al. 2010). However, alcohol 
consumption is usually defi ned according to the number of drinks per week; light 
or moderate drinking when the consumption is no more than 7 drinks per week 
or 3 drinks on a single day for females, and 14 per week or 4 on a single day for 
males (National Institute on Alcohol Abuse and Alcoholism 2005). Heavy drinking 
refl ects either higher overall use or occasions of high use.
According to the National Institute for Health and Welfare (THL) (Jääskeläinen & 
Virtanen 2011), the average total consumption of alcoholic beverages has risen about 
one litre of pure alcohol per resident from 1990 to 2010 in Finland. Further, alcohol 
use is common, with almost 90% of Finnish adults reporting alcohol consumption 
during the previous year (Helakorpi et al. 2011). However, the consumption has 
changed towards mild alcoholic beverages. Most of the consumption consists of 
beer and most of the consumed alcoholic beverages (86% in 2010) are derived from 
retail sale (Jääskeläinen & Virtanen 2011). The average starting age of alcohol use is 
rather young in Finland, being around 14–16 years, which is in line with the starting 
age of many other countries (Prescott & Kendler 1999, Rose et al. 1999, Rose et 
al. 2001, Young et al. 2002, Patton et al. 2007, Pitkänen et al. 2008, Eliasen et al. 
2009). Furthermore, students and young adults aged between 18 and 22 years often 
consume large amounts of alcohol; this is often the period of the heaviest drinking 
during the lifetime (Kandel & Logan 1984, Chen & Kandel 1995, Grant & Dawson 
1999, Clark 2004, Schuckit 2009). However, this does not necessarily mean that 
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alcohol dependence will develop because during early adulthood alcohol use and 
even binge drinking may be part of the social culture among young adults (Perkins 
2002, Clark 2004, Kuntsche, Rehm & Gmel 2004). 
The intoxicating substance in alcoholic beverages, ethyl alcohol or ethanol, is 
mainly responsible for the addiction-causing properties. Its action is mediated by 
GABA and NMDA receptors, and it also causes increasing release and fi ring of 
dopamine neurons when the blood concentration of ethanol rises (Moak & Anton 
1999). Ethanol is produced in beverages by the fermentation of yeast, sugars, and 
starches. Its chemical structure is simple, and it easily crosses the blood-brain 
barrier. Although most effects of ethanol are depressant, it has a biphasic nature; 
at lower doses, it increases activity and reduces inhibitions and at higher doses 
it causes depression of cognitive, perceptive, and motor functions (World Health 
Organization 2004). As with nicotine, however, not all individuals experience the 
effects similarly, and especially the effects on mood and emotions vary greatly. 
Only a few studies of the role of alcohol or ethanol in the aetiology of bruxism 
exist, and these present partly contradictory results (Hartmann 1979, Hartmann et 
al. 1987, Molina et al. 2001, Ohayon, Li & Guilleminault 2001, Bellini et al. 2011, 
Kato et al. 2012, Abe et al. 2012). Alcohol use in these studies has been analyzed 
using different alcohol quantities (Table 2). None of these studies used specifi c 
drinking patterns together with alcohol quantities. In his fi rst study, Hartmann 
(1979) used self-reported alcohol consumption from one to four drinks per day as 
a measure of alcohol use. In their later clinical trial, Hartmann et al. (1987) used 
precisely measured doses of alcohol (dose = 226 mg/kg of ethanol) in a double-
blind approach. Abe et al. (2012) also measured alcohol intake by ml/day. Ohayon 
et al. (2001), by contrast, classifi ed alcohol consumption as glasses per day (zero, 
one or two, and at least three), while Molina et al. (2001), Bellini et al. (2011), and 
Kato et al. (2012) measured alcohol use only as yes or no.
In the fi rst case study by Hartmann (1979), the role of alcohol as a risk factor for 
bruxism was analysed based on four patients and their bed partners’ reports about 
their bruxism. On average, patients reported alcohol use of one to four drinks per 
day, and according to their bed partners’ reports more episodes of bruxism occurred 
on the days with alcohol use. Further, using polysomnographic information about 
one patient, Hartmann reported more bruxism episodes on days with three drinks 
than on alcohol-free days. However, no statistical analyses were performed in their 
study. Later, Hartmann et al. (1987) performed a sleep laboratory-based double-
blinded clinical trial with 16 patients. They gave patients 0 (placebo) to 4 alcoholic 
drinks to reveal possible effects of alcohol on sleep bruxism. However, they failed 
to fi nd any signifi cant effect of acute alcohol exposure on bruxism, although there 
was a slight trend towards higher levels of alcohol intake being associated with 
more bruxism.
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Ohayon et al. (2001) estimated that alcohol use raises the risk of sleep bruxism 
by 1.5–1.8 depending on the daily consumption rate, while Molina et al. (2001), 
Kato et al. (2012), and Abe et al. (2012) found no signifi cant association between 
bruxism and alcohol consumption. Further, Bellini et al. (2011) noted a trend for 
more alcohol consumers among bruxers than among non-bruxers in general.
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Summing up, according to the existing studies, the role of alcohol as the risk 
factor for bruxism is unclear and the odds for bruxism among alcohol consumers 
seems to vary greatly between studies from no association to almost 2 times higher 
incidence.
2.1.6.3. Coffee and bruxism  
Coffee is one of the most consumed beverages worldwide. Alongside many other 
substances, it contains caffeine, which acts as psychoactive substance (Minamisawa, 
Yoshida & Takai 2004). In Finland, coffee consumption is quite high relative to 
the average European consumption, being 12.2 kg of coffee (weight in green bean 
equivalent, 1 kg of green coffee beans = 0.84 kg of roasted coffee) per person in 
the year 2010 (International Coffee Organization 2010).  The overall use of other 
beverages containing caffeine (tea, soft drinks with caffeine, energy drinks) together 
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with decaffeinated coffee is lower than coffee consumption. Both positive and 
negative health effects of coffee and caffeine have been widely studied, and caffeine 
is known to cause addiction and dependence (Laitala, Kaprio & Silventoinen 2008). 
Coffee consumption seems to have remained moderately stable over time in Finland, 
and it has an essential role in Finnish culture among adults, and thus, most adults 
are exposed to coffee regularly (Laitala, Kaprio & Silventoinen 2008). Genetic factors 
affect the consumption of coffee (Swan, Carmelli & Cardon 1996, Hettema, Corey 
& Kendler 1999, Kendler & Prescott 1999, Luciano et al. 2005, Reynolds, Barlow & 
Pedersen 2006, Laitala, Kaprio & Silventoinen 2008). There seems to be a common 
genetic pathway affecting the use of tobacco, alcohol, and coffee (Swan, Carmelli 
& Cardon 1996, Hettema, Corey & Kendler 1999), and according to Laitala et al. 
(2009), heavy coffee consumption is associated with female gender, a lower level 
of education, a higher BMI, and smoking.
Caffeine is a psychoactive substance that causes mainly stimulant effects 
(Salaspuro et al. 2003) and is one of the most consumed psychoactive substances 
in the world. Its stimulant effects include increased mental alertness, wakefulness, 
and faster information processing as well as alterations to sleep such as delayed sleep 
onset, reduced total sleep time, modifi ed sleep stages, and deteriorated quality of 
sleep (Goldstein, Warren & Kaizer 1965, Heath et al. 1998, Harland 2000). Although 
coffee has a variety of other biological effects and contains many biologically active 
substances (Minamisawa, Yoshida & Takai 2004), the psychoactive effects mediated 
by caffeine cause the potential dependence. 
Previous studies on coffee intake as a risk factor for bruxism are rare (Table 
3). Only four studies were found (Bastien, Gale & Mohl 1990, Molina et al. 2001, 
Ohayon, Li & Guilleminault 2001, Abe et al. 2012) (Table 3). Bastien et al. (1990) 
performed a placebo-controlled study recording nocturnal masseteric muscle 
activity via a portable electromyograph recording unit. They gave either placebo 
or caffeine to 14 volunteers. However, they failed to show any signifi cant association 
between rising muscle activities and caffeine ingestion. Later, Molina et al. (2001) 
found that the severity of bruxism worsens with increasing coffee consumption. 
Ohayon et al. (2001) estimated that the consumption of six or more cups of coffee 
daily raised the risk for bruxism 1.4-fold. However, in a questionnaire and sleep 
laboratory-based study, Abe et al. (2012) found no signifi cant association between 
caffeine intake and bruxism. 
32
2. REVIEW OF THE LITERATURE








































































No signiﬁ cant 
association
Summing up, in few existing studies, the results for the association between 
coffee consumption and bruxism have not been consistent and there have been 
great variation in study design and methods and thus, the evidence of coffee as 
risk factor for bruxism is unclear.
2.2 TWIN STUDIES AND HERITABILITY
A twin is an individual from a two-offspring pregnancy. Twins can be divided into 
identical or monozygotic (MZ) and non-identical or dizygotic (DZ) twins based on 
development as a zygote. MZ twins develop from a single egg cell or one zygote 
that splits, forming two embryos with identically inherited genetic material, and 
thus, MZ twins share 100% of their genes. DZ twins, by contrast, develop from two 
separate egg cells, forming two individual embryos, and therefore, DZ twins share 
on average only 50% of their segregating genes, like normal siblings do. Twins are 
further classifi ed into fi ve different zygosity-sex groups: monozygotic males (MZM), 
monozygotic females (MZF), dizygotic males (DZM), dizygotic females (DZF), and 
opposite-sex dizygotic twins (DZ-OS). 
2.2.1. THE CLASSICAL TWIN METHOD 
Human behavior and diseases are affected by both genetics and the environment. 
Individuals’ differences from each other in relation to any phenotype may be 
caused by either genetic or environmental factors. Therefore, the twin situation 
can be exploited to estimate the heritability of a given trait using either intrapair 
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correlations or concordance rates (Boomsma, Busjahn & Peltonen 2002). 
Heritability (h2) expresses the proportion of the phenotypic variance of the trait 
that is explained by genetic variance. Twin pregnancies are often considered 
normal singleton pregnancies in twin studies focusing on environmental and 
genetic factors. However, compared with actual singleton pregnancies, there may 
be developmental differences or differences in the intrauterine environment in 
twin pregnancies that affect the development of any given trait in later life (Hall 
2003). Twins share varying amounts of genes while they also share a common 
environment if they are not reared apart. In addition, every twin individual has a 
unique environment apart from the one shared with the twin sibling. All of these 
can affect a given trait when the trait is not fully genetically regulated. Further, 
there may be some gene-environment interaction that affects the particular trait, 
meaning that genes may change the effects of exposure to environmental factors, 
certain genes may be more common in a certain environment, or environmental 
factors can alter gene expression (Plomin, DeFries & Loehlin 1977, Eaves 1984, 
Kendler, Eaves 1986, Boomsma, Busjahn & Peltonen 2002, Purcell 2002). 
The extent of genetic variation determining the phenotypic variation of a given 
trait can be estimated by comparing the phenotypic resemblance of MZ and DZ 
twins. Any purely heritable disease will be more concordant among MZ than DZ 
twins, while any purely environmentally affected disease will be equally common 
between MZ and DZ twins (Boomsma, Busjahn & Peltonen 2002). When the trait is 
infl uenced by inherited genes as well as environmental factors, then the proportion 
of the shared environment can be estimated by deducting the genetically explained 
proportion from the total twin correlation. Because of the shared genetic background 
of MZs, any situation where one twin of the pair has a disease and his/her co-
twin has not (discordant twin pair) could be explained by the different exposure to 
environmental risk factors. By contrast, in the case of DZ twins, where on average 
half of the genes are shared, an intrapair difference in a disease outcome could be 
explained by either environmental or genetic factors. Also, heritability can vary 
between sexes and the opposite-sex situation of DZ twins helps in the study of 
sex-specifi c factors affecting any trait being examined. Still, the result of heritability 
proportion affecting the trait does not tell whether the heritability derives directly 
from disease genes or whether it comes from the indirect effects of heritability (say 
acting on the risk factors for that disease). Despite this limitation, the twin case-
control (twin vs. co-twin) situation creates an excellent situation for the evaluation 
of the importance of genetic variation to the susceptibility of a given trait.
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2.2.2. THE DISCORDANT TWIN PAIR DESIGN TO TEST CAUSALITY 
The situation of discordant twin pairs (where one twin is affected while the other is 
not) can be exploited when the focus of the study is on comorbidity or association 
of two characteristics. The classical twin method can be used to test whether this 
association is caused by genetic or environmental factors. Discordant twin pairs 
can also be used to control for genetic and environmental factors that may underlie 
the association by testing whether the association is present even after adjustment 
for unmeasured familial and genetic factors. Further, discordant twin pair design 
or the co-twin control design can be used to test causality (one trait causing the 
other) (Cederlof, Friberg & Lundman 1977, Kendler et al. 1993, Kujala, Kaprio & 
Koskenvuo 2002, Ligthart, Boomsma 2012). The design tests the intrapair risk for 
the other trait (B) when the twin pair is discordant for the fi rst trait (A). If there is 
causality in the association of the studied traits (A raises the risk for B), then the 
twins of the pairs affected with the fi rst trait (A) are also the twins with a higher 
risk of being affected with the other trait (B). In addition, discordant twin design 
results can be generalized to the general population so that individuals with trait 
A have an increased risk for trait B relative to individuals with no trait A (Ligthart 
& Boomsma 2012).
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3. AIMS OF THE STUDY
The main aim of this study was to examine the role of genetic and environmental 
factors in sleep-related bruxism using young adult and middle-aged Finnish twins. 
A special emphasis was placed on three psychoactive substances (tobacco, alcohol, 
and coffee) as risk factors for sleep-related bruxism.
Specifi c aims of the study:
 I. To quantify the relative roles of genetic and environmental    
  factors in sleep-related bruxism (Study I)
 II.  To examine the role of smoking and nicotine dependence in the   
  risk of sleep-related bruxism (Studies II-III)
 III. To examine the role of alcohol use in the risk of sleep-related   
  bruxism (Study IV)
 IV.  To examine the role of coffee consumption in the risk of sleep-  
  related bruxism (Study IV)
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4. MATERIALS AND METHODS 
4.1. DATA SETS
The material of the present study originates from two large twin cohort studies: 
the FinnTwin16 study and the Finnish Twin Cohort study, with a subsample of 
nicotine-dependent subjects (NAG Finland). Material for Substudies I-II derives 
from the FinnTwin16 study and material for Substudies III and IV from the Finnish 
Twin Cohort study. The data and methods used in the substudies are presented 
in Table 4.
4.1.1. FINNTWIN16 
FinnTwin16, a nationwide longitudinal Finnish twin cohort study of fi ve birth 
cohorts born in 1975–1979, comprises 3065 twin pairs. Twins were identifi ed 
from the Central Population Registry of Finland (Kaprio, Pulkkinen & Rose 2002). 
The study protocol was approved by the Ethics Committee of the Department of 
Public Health, University of Helsinki, Finland, and the Institutional Review Board 
of Indiana University, Pennsylvania, USA. Subjects were informed of the goals of 
the study and provided their informed consent.
Twins received comprehensive questionnaires about general health and lifestyle 
on four separate occasions. The fi rst questionnaire was distributed when twins were 
16 years of age in 1991–1995. Follow-up questionnaires were sent when the twins 
were aged 17 and 18.5 years, and a fourth wave at the stage of early adulthood in 
2000–2002 (average age 24 years, range 23–27 years). The response rate was 88% 
in the fourth survey (Kaprio 2006). Oral health questions were asked only of twins 
born in 1975–1978; twins born in 1979 were thus excluded from the analyses of 
this study. Questionnaires included multiple health-related questions on general, 
mental, and oral health, as well as questions on common lifestyle factors such as 
smoking. The oral health question covered fi llings, gingival bleeding, bruxism, and 
wisdom teeth, as well as experienced oral health and self-rated need for dental care.
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4.1.2. FINNISH TWIN COHORT 
The Finnish Twin Cohort is a nationwide longitudinal Finnish twin study. It 
comprises health questionnaires sent on four occasions to adult Finnish twins born 
before 1958. Questions about bruxism were posed in the third questionnaire sent 
to the twins in 1990. Twins (n=12 502 twin individuals) responding to the third 
questionnaire were born between 1930 and 1957, and their mean age was 44 years 
(Hublin et al. 1994, Hublin et al. 1997). The response rate to the third questionnaire 
was 77%. The Ethics Committee of the Department of Public Health, University of 
Helsinki, Finland, approved the study protocol. Subjects were informed about the 
goals of the study and provided their informed consent. 
The third questionnaire consisted of 103 multiple choice questions about general 
health and health habits, tobacco and alcohol use, and sleep and vigilance matters, 
including also perceived bruxism in childhood and adulthood (Hublin & Kaprio 
2003). Consumption of coffee was not included in the third questionnaire, but was 
asked about in the fi rst and second questionnaires in 1975 and 1981.
SUBSAMPLE OF NICOTINE ADDICTION GENETIC (NAG) 
For the studies of nicotine addiction, ever-smoking twin pairs concordant for heavy 
smoking (twin pairs where both twins are heavy smokers) from the Finnish Twin 
Cohort study were recruited to join the Nicotine Addiction Genetics Finland Study 
(NAG Finland) (Broms et al. 2007, Loukola et al. 2008). The subsample included 
both same-sex and opposite-sex twin pairs, their siblings, and some other family 
members (Kaprio & Koskenvuo 2002). The data were collected via telephone 
interview in 2001–2005 (Broms et al. 2007, Loukola et al. 2008). The mean age 
of the twins was 53.7 years. Altogether 445 twin individuals had answered the 
bruxism question in the 1990 questionnaire. Although the subsample focused on 
nicotine dependence, there were also question about major depressive disorder, 
alcohol dependence, and nicotine use. The Ethics Committee of the Hospital District 
of Helsinki and Uusimaa, Finland, approved the study protocol in 2001, and all 
subjects gave their written informed consent,
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4.2. STUDY VARIABLES 
BRUXISM 
In the FinnTwin16 study (Studies I-II), bruxism was evaluated with the following 
question: Do you grind your teeth? The response options were 1) every night, 2) 
weekly, 3) once in a while, 4) never, and 5) I do not know. Twins (n=3126) were 
classifi ed into three groups, where alternatives 1) and 2) were classifi ed as ‘weekly 
bruxism’, alternative 3) as ‘rare bruxism’, and alternative 4) as ‘never bruxism’, which 
was also our reference category. Those who were unaware of their bruxism habit 
(n=648) were excluded from the analyses. For some analyses, those responding to 
the fi rst three alternatives were defi ned as having ‘any bruxism’.  
In the Finnish Twin Cohort study (Studies III and IV), bruxism was evaluated 
with the following question: Do you grind your teeth? The response options were 
1) weekly, 2) monthly, 3) occasionally, 4) never, and 5) I do not know. Twins (n=10 
229) were classifi ed into four groups, where alternative 1) was classifi ed as ‘weekly 
bruxism’, alternative 2) as ‘monthly bruxism’, alternative 3) as ‘occasional bruxism’, 
and alternative 4) as ‘never bruxism’, which was also our reference category. Those 
who were unaware of their bruxism habit (n=1817) were excluded from the analyses. 
USE OF TOBACCO PRODUCTS
In the FinnTwin16 study (Study II), smoking status was assessed with the following 
question: “Of the following options, which best describes your present smoking?” 
The response options were 1) I smoke at least 20 cigarettes a day, 2) I smoke 10–19 
cigarettes a day, 3) I smoke no more than 9 cigarettes a day, 4) I smoke weekly or 
often but not on daily basis, 5) I smoke less than once a week, 6) I do not smoke 
at the moment or I have quit smoking, and 7) I have never smoked. Daily smokers 
were classifi ed into two groups: heavy smokers (at least 10 cigarettes daily) and 
light smokers (less than 10 cigarettes daily and including those not smoking daily). 
Those who answered alternative 6) were classifi ed as former smokers and those 
who reported never smoking were classifi ed as never-smokers, and they were also 
the reference category in analyses. Other smoking habits where evaluated with the 
question: “Do you smoke cigars, cigarillos, or the pipe?” Response options were 1) 
never, 2) once in a while, and 3) regularly. There were only a few individuals who 
reported smoking regularly so we dichotomized the use of these other tobacco 
forms as cigar users (alternatives 2 and 3) vs. never. The third question related to 
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tobacco products evaluated the use of smokeless tobacco: “Have you tried smokeless 
tobacco (placed in the sulcus of the upper lip)? How many times?” The response 
options were 1) I have never tried, 2) I have tried once, 3) I have used 2–50 times, 
4) I have tried more than 50 times, and 5) I use smokeless tobacco regularly. We 
then classifi ed the use of smokeless tobacco as follows: never, occasional lifetime 
users (1–50 times), and regular users (> 50 times or use regularly by self-report).
In the Finnish Twin Cohort study (Study III), the use of tobacco was assessed 
with multiple questions. Never-smoker status was determined by asking “Have 
you smoked more than 5–10 packs of cigarettes during your entire life?”. Those 
who reported smoking less than 5–10 packs (i.e. 100–200 cigarettes) in their 
entire life were categorized as never-smokers. The next question separated current 
smokers from occasional smokers; subjects who had never smoked regularly, but 
could not be classifi ed as never-smokers were categorized as occasional smokers. 
Those categorized as former smokers indicated that they had smoked regularly, 
i.e. daily or almost daily, but had quit smoking later. The rest were categorized as 
current smokers. They were also asked to report the number of cigarettes smoked 
per day. The response options were 1) none, 2) less than 5, 3) 5–9, 4) 10–14, 5) 
15–19, 6) 20–24, 7) 25–39, and 8) more than 40. We classifi ed current smokers as 
light smokers (less than 10), smokers of 10–19 cigarettes daily, smokers of 20–24 
cigarettes daily, and heavy smokers (at least 25 cigarettes daily). We also enquired 
about the age of starting to smoke regularly. Lifetime pipe or cigar smoking was 
categorized dichotomously, with a user defi ned as someone reporting having ever 
smoked at least 50 cigars, 75 cigarillos, or more than 3–5 packages of pipe tobacco 
(Hukkinen et al. 2009). 
NICOTINE DEPENDENCE 
Nicotine dependence (Study III) was assessed using a substudy of the Nicotine 
Addiction Genetics Finland Study (NAG; an international consortium among 
Finland, Australia, and USA). The participants needed to be ever-smokers because 
nicotine dependence requires a nicotine habit to develop. We categorized nicotine 
dependence dichotomously as either nicotine-dependent or non-dependent. 
Nicotine dependence was assessed with the DMS-IV scale in which participants 
meeting at least 3 of the 7 criteria within the last year were defi ned as dependent 
(American Psychiatric Association 1994). The 7 criteria of nicotine dependence in 
the DMS-IV scale are the following: 
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1. Tolerance, as defi ned by either a need for increased amounts 
of the substance in order to achieve the desired effect or a 
markedly diminished effect with continued use of the same 
amount
2. Withdrawal, as manifested by either the characteristic 
withdrawal syndrome for the substance or the same (or 
closely related) substance taken to relieve or avoid withdrawal 
symptoms
3. Substance often taken in larger amounts or over a longer period 
than intended
4. Persistent desire or unsuccessful efforts to cut down or control 
use
5. A great deal of time spent in activities necessary to obtain the 
substance or to recover from its effects
6. Important social, occupational or recreational activities given 
up or reduced because of substance use
7. Continued substance use despite knowledge of having a 
persistent or recurrent physical, psychological, or social 
problem that is likely caused or exacerbated by the use of the 
substance
ALCOHOL USE
The use of alcohol (Study IV) was assessed in the Finnish Twin Cohort study 
with four multiple choice questions dealing with information about the amount of 
alcoholic beverages consumed, the frequency of alcohol use, the frequency of binge 
drinking monthly, and the number of times passing out due to alcohol during the last 
year. The amount of alcohol beverages consumed was evaluated with the following 
question: How much on average do you consume of beer weekly, wine weekly, and 
spirits monthly? The frequency of alcohol use was evaluated with the following 
question: How often do you consume alcohol? Please give separate estimates for 
beer, wine, and spirits. According to the amount of consumed alcohol and the 
frequency of alcohol use, the answers were computed to derive the weekly alcohol 
intakes (Kaprio et al. 1987). The subjects were then categorized into four groups: 
abstainers, light drinkers (≤3 drinks per week), moderate drinkers (>3 to ≤7 drinks 
per week for women and >3 to ≤14 for men), and heavy drinkers (>7 drinks per 
week for women and >14 for men), as described elsewhere (Järvenpää et al. 2005). 
Binge drinking was assessed dichotomously with the following question: Do you 
drink more than fi ve bottles of beer at least once a month, one bottle of wine, or half 
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a bottle of spirits (or the equivalent amounts of other alcoholic beverages) on the 
same occasion? The fourth question dealt with passing out due to excessive alcohol 
intake within the last year. The outcomes were categorized into three groups: never, 
once, and two or more times (Virta et al. 2010). 
COFFEE CONSUMPTION
Coffee consumption (Study IV) was not asked about in the questionnaire in 1990 
in the Finnish Twin Cohort. Instead, it was enquired about in the 1975 and 1981 
surveys, and for this study we used information gathered in 1981 because it was 
chronologically closer to the 1990 survey. Coffee consumption was evaluated with 
the following question: “How many cups of coffee do you drink daily?”. Participants 
who did not drink coffee daily were asked to record the answer zero. According to 
the answers, coffee consumption was divided into three categories: 0–3 cups per 
day, 4–8 cups per day, and more than 8 cups per day. 
SOCIAL CLASS
Information about social class (Study IV) was assessed in the Finnish Twin Cohort 
study with an open question ‘What is your occupation, or if you are not working at 
the moment: what was your earlier occupation? Describe it as precisely as possible.’ 
According to the classifi cation of the Central Statistical Offi ce of Finland’s using 
occupational information (Kaprio & Koskenvuo 1988, Broms et al. 2004, Ropponen 
et al. 2011, Offi cial Statistics of Finland 2012), social class was then categorized as 
white-collar, bluecollar, or others. 
DETERMINATION OF ZYGOSITY 
Twins’ zygosity was determined using an accurate and validated questionnaire 
method that focuses on twins’ similarity and genetically infl uenced characteristics 
(Sarna et al. 1978). The validity of the method was further studied in a subsample 
using 11 blood markers (Sarna et al. 1978). This determination method leaves about 
7% of twin pairs unclassifi ed, while the probability of misclassifi cation is as low as 
1.7%. 
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4.3. STATISTICAL METHODS 
The statistical analysis used was appropriate to the study design and the purposes 
of each original study (Table 4). Cross-sectional and longitudinal analyses as well 
as genetic modelling were used as in the original studies as follows:
 –  Studies I: Quantitative genetic modelling based on the genetic   
  similarity of identical and non-identical twins was used to calculate 
  the most probable genetic model for bruxism.
 –  Studies II-IV: Multinomial logistic regression was used to explore the  
  relationships of frequency of bruxism with the psychoactive substances  
  of tobacco, alcohol, and coffee. Conditional logistic regression models  
  were used to obtain odds ratios (ORs) for the risk of bruxism in relation  
  to the use of psychoactive substances in twin pairs discordant for   
  bruxism.
4.3.1. DESCRIPTIVE STATISTICS AND ANALYSES BETWEEN BRUXISM AND RISK 
FACTORS IN INDIVIDUALS
Descriptive statistics and polychoric correlations are calculated with the Stata 
program (StataCorp 2005). The associations of the use of psychoactive substances 
and bruxism are assessed using cross-tabulations, the Pearson chi-square test of 
independence, and multinomial logistic regression models (Hosmer & Lemeshow 
2000) adjusted for covariates. Odds ratios (ORs) and their 95% confi dence intervals 
(CIs) of all models are adjusted for correlated observations within twin pairs by 
means of Stata 9.0 (StataCorp 2005) using a robust estimator of variance (Williams 
2000). Conditional logistic regression models are used to obtain ORs for bruxism 
in relation to psychoactive substances in twin pairs discordant for bruxism. 
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Table 4. Data and methods used in substudies
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4.3.2. GENETIC MODELLING 
The comparison of monozygotic (MZ) and dizygotic (DZ) twins, based on the fact that 
monozygotic twins share 100% of their genes and dizygotic twins on average share 
only 50% of their segregating genes, provides estimates about the heritability. Twins 
are classifi ed into fi ve different zygosity-sex groups: monozygotic males (MZM), 
monozygotic females (MZF), dizygotic males (DZM), dizygotic females (DZF), and 
opposite-sex dizygotic twins (DZ-OS). The correlation expected for both additive 
and non-additive effects is 1.0 in MZ pairs and in DZ pairs the correlation expected 
for additive genetic effects is 0.5 and for non-additive effects 0.25. 
We used the quantitative genetic methods based on structural equation modelling 
(Neale & Cardon 1992) to analyse the data. Quantitative genetic modelling compares 
different models to permit estimation of variance components. First, we assessed 
some of the assumptions of the twin model by comparing the fully saturated model 
(i.e. one where all model parameters were free to vary) with more constrained 
models, providing statistical tests for the assumption that the given characteristics 
do not differentiate in the subgroups of the population and the twins are thus 
representative. This was done by requiring the distributions of the bruxism to be: 
a) the same among fi rst- and second-born twins, b) the same in MZ and DZ twins, 
and c) the same in men and women. 
Next, the formal estimation of variance components was divided into four possible 
phenotypic variance components: additive genetic effects (A), non-additive genetic 
effects (D), shared environmental effects (C), including all experiences affecting both 
twins similarly (such as childhood diet), and non-shared environmental effects (E), 
including all experiences affecting only one member of the twin pair. The baseline 
model was the ACE/ADE model. We tested more restrictive two-parameter models 
(AE, CE) and the pure E model, which specifi es that no familial aggregation exists 
for the trait being examined against the baseline model. 
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In addition, we estimated the possible sex-specifi c genetic variation by comparing 
same-sex twin pairs to opposite-sex twin pairs. The sex-limitation model (Neale & 
Cardon 1992) utilizes the information from opposite-sex pairs and tests whether 
genes specifi c to one sex, sex-specifi c common environmental effects, or sex-specifi c 
additive genetic effects affect the variation in bruxism. The model tests whether the 
magnitudes of A, D, and E are affected equally in the sexes and whether a constraint 
to this weakens the fi t of the model. Sex-specifi c effects for the given character are 
expected if the correlations within opposite-sex pairs are smaller than those for 
same-sex pairs. 
The best-fi tting model is found by using the χ² difference test and degrees of 
freedom (df) between the more complex model and the more constrained model 
(e.g. ACE vs. AE tests for the presence of signifi cant C effects). We calculated genetic 
modelling with the Mx program (Neale et al. 2003) to estimate the CIs for the 
pairwise tables grouped by sex and zygosity of the trait in twin 1 versus the trait 




5.1. The related roles of genetic and environmental factors in 
self-reported bruxism (Study I)
The genetic architecture of self-reported bruxism (Study I) was investigated using 
the FinnTwin16 cohort study. Basic genetic modelling was carried out for the self-
reported bruxism among young adults. All monozygotic polychoric correlations were 
higher than the dizygotic ones (Table 5). According to fully saturated models, the 
prevalence for the variables did not differ by sex. The best-fi tting model for bruxism 
was the AE model, and according to sex-limitation analyses, no sex differences or 
sex-specifi c genes were found. The relative proportions of variance components 
are shown in Figure 1.
Table 5. Pairwise similarity of bruxism in young adults (FinnTwin 16). Polychoric correlations by sex and 
zygosity.
                                           Bruxism
 Correlation coefﬁ cient 95% conﬁ dence interval
All monozygotic pairs 0.55 0.44–0.67
   Male monozygotic pairs 0.43 0.21–0.65
   Female  monozygotic pairs 0.61 0.48–0.74
All dizygotic pairs 0.20 0.09–0.30
   Male dizygotic pairs 0.26 0.05–0.47
   Female dizygotic pairs 0.10 -0.12–0.33
   Opposite-sex dizygotic pairs 0.22 0.07–0.37
Figure 1. Relative proportions of variance components in bruxism (FinnTwin16). 
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5.2. Prevalence of bruxism (Studies I-IV)
Prevalence of bruxism was assessed in Studies I-IV using data from both the 
FinnTwin16 study (adulthood bruxism) and the Finnish Twin Cohort study 
(childhood and adult bruxism). There were questions about both childhood and 
current bruxism in the Finnish Twin Cohort study and questions about current 
bruxism in the FinnTwin16 study. Prevalence of childhood, adulthood, and adult 
bruxism is shown in Figures 2–4 separately for the sexes.
For the question on childhood bruxism, 11977 subjects responded and 27.3% of 
them did not know whether they had experienced bruxism in childhood. A signifi cant 
gender difference was found in the prevalence of childhood bruxism (p<0.001) 
(Figure 2.). For the question on adulthood bruxism, by contrast, 3774 subjects 
responded and 17.2% of them were uncertain whether they experienced bruxism. 
No signifi cant gender difference was seen in the prevalence of adulthood bruxism 
(p=0.054) (Figure 3.). Regarding bruxism in adults, 12 046 subjects answered 
the question and 15.1% of them could not tell whether they experienced bruxism 
or not. There was a signifi cant gender difference in bruxism in adults (p=0.003) 
(Figure 4.). Again, prevalence of bruxism (childhood, adulthood, and adult) did 
not differ signifi cantly between MZ and DZ twins (p=0.1257, p=0.63, and p=0.64, 
respectively). 
Figure 2. Prevalence of childhood bruxism (Finnish Twin Cohort), n=8703.
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Figure 3. Prevalence of adulthood bruxism (FinnTwin16), n=3126.
Figure 4. Prevalence of adult bruxism (Finnish Twin Cohort), n=10 229.
5.3. Prevalence of psychoactive substance use (Studies II-IV)
The prevalence of psychoactive substances (tobacco, alcohol, and coffee) was 
assessed in Studies II-IV using data from both the FinnTwin16 study and the 
Finnish Twin Cohort study. In the FinnTwin16 study, there were questions about 
smoking and the use of smokeless tobacco. In the Finnish Twin Cohort study, on 
the other hand, there were questions about smoking and nicotine dependence, 
alcohol use, and coffee consumption. The prevalence of psychoactive substances 
(smoking, alcohol use, and coffee consumption) is shown in Figure 5 and Table 6.
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Figure 5. Prevalence of adulthood smoking and the use of smokeless tobacco (FinnTwin16), n=3124.
Table 6. Prevalence (%) of adult smoking and the amount smoked (cigarettes per day, CPD), alcohol use, 
and coffee consumption separately for men and women (Finnish Twin Cohort)
Psychoactive substance Class of consumption/amount consumed
Smoking Current Former Occasional Never
Men (n=5512) 31.4 29.4 4.0 35.1
Women (n=6601) 21.1 17.4 3.0 58.5
CPD >24 20–24 10–19 <10
Men (n=2091) 14.9 24.7 30.7 29.8
Women (n=1619) 4.8 12.0 38.1 45.2
Alcohol consumption Heavy Moderate Light Abstainer
Men (n=5668) 19.8 48.2 23.3 8.8
Women (n=6748) 10.1 22.6 47.2 20.0
Binge drinking Yes No
Men (n=5609) 44.9 55.1
Women (n=6686) 12.2 87.8   
Passing out 2< 1 Never
Men (n=5633) 12.5 8.91 78.6
Women (n=6667) 2.85 4.14 93.0  
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5.4. Association between bruxism and psychoactive substances 
(Studies II-IV)
5.4.1. SMOKING AND BRUXISM 
In young adults (FinnTwin16), weekly bruxism was more common among heavy 
smokers and among those using snuff regularly (Figure 6). It was also signifi cantly 
associated with smoking when age and gender were controlled. In addition, women 
reported more weekly bruxism when smoking was controlled (p<0.001). According 
to multinomial logistic regression, those with weekly bruxism were two times more 
likely to be heavy smokers than never-smokers (OR 2.5). Also, the use of smokeless 
tobacco raised the odds for bruxism. Detailed ORs and CIs of smoking and the use 
of smokeless tobacco in relation to weekly bruxism are shown in Figure 7. In young 
adults, the signifi cant association of heavy smoking and smokeless tobacco with 
weekly bruxism held when the effects of other forms of tobacco use and psychoactive 
substance use (alcohol drinking to intoxication, drug use, and coffee consumption) 
were adjusted in the analyses. According to our analyses, both heavy smoking and 
smokeless tobacco raised the odds for weekly bruxism about twofold (heavy smoking 
OR 1.93 and smokeless tobacco OR 2.05). Conditional logistic regression analyses of 
young adults revealed that heavy smoking was strongly associated with any bruxism 
in opposite-sex dizygotic twin pairs (OR 2.4, 95% CI 1.2–4.8) (Table 7).




In middle-aged adults, weekly bruxism was more common among both male 
and female smokers and also among current heavy smokers relative to current light 
smokers (Figure 8). According to multinomial logistic regression, weekly bruxism 
was associated with current smoking (OR 2.85). Of the current smokers, those 
smoking 20 or more cigarettes per day were more likely to report weekly bruxism 
than those with less cigarettes per day. Detailed ORs and CIs of smoking status 
and amount of current smoking in relation to weekly bruxism are shown in Figure 
11. Also, current smoking with a nicotine dependence diagnosis raised the odds for 
weekly bruxism signifi cantly (OR 2.50, 95% CI 1.06–5.87) compared with current 
smoking without such a diagnosis. Unlike in young adults, there was no signifi cant 
effect of gender on bruxism. Contrary to weekly bruxism, both current smoking and 
former smoking were associated with monthly bruxism (OR 1.74, 95% CI 1.37–2.22 
and OR 1.64, 95% CI 1.27–2.11, respectively). 
Figure 7. Multinomial logistic regression: Detailed ORs and CIs of smoking, snuff use, and cigar smoking in 
relation to weekly bruxism (FinnTwin16 Cohort). Model I adjusted for age and sex, and model II adjusted 































































































































































































































































































































































































































































































































































































































Figure 8. Proportions of ‘weekly’ bruxism in adults by smoking status (n=9955) and the amount smoked 
by current smokers (n=2604), with men and women shown separately (Finnish Twin Cohort). 
The risk of bruxism was further analysed using twin pairs discordant for smoking 
status to test whether the association exists even when the unmeasured familial 
and genetic factors are adjusted. We used twin pairs in which either the twin with 
tobacco use reports also bruxism while the other twin reports neither tobacco use 
nor bruxism or the pairs in which the one with tobacco use reports no bruxism 
and the co-twin reports no tobacco use but does report bruxism. In middle-aged 
adults, there were 142 discordant twin pairs. Of the monozygotic twin pairs, there 
were 13 pairs where one twin reported weekly bruxism and the other reported 
never-bruxism and where one twin reported current smoking and the other was a 
non-smoker. In all of these pairs, the twin who reported weekly bruxism was also 
the one who reported current smoking (McNemar Chi-square test, p=0.0003). 
5.4.2. ALCOHOL USE AND BRUXISM
Weekly bruxism was more common among heavy drinkers than among moderate 
drinkers or abstainers (7% vs. 4% vs. 3%). Proportions of weekly bruxism by alcohol 
use are shown in Figure 9. Also, the severity of bruxism increased with an increasing 
number of alcoholic drinks, and when alcohol consumption was calculated as grams 
of alcohol per day (log-transformed) it was also associated with weekly bruxism 
(p=0.017). This association with bruxism held even when smoking status was 
controlled. In age- and gender-adjusted multinomial logistic regressions, moderate 
and heavy drinking, binge drinking, and passing out were associated with weekly 
bruxism. Detailed ORs and CIs of alcohol use in relation to weekly bruxism are 
shown in Figure 11. When smoking status was adjusted in the model, heavy drinking, 
binge drinking, and passing out at least two times during the last year retained 
their statistical signifi cance, although the ORs decreased (Figure 11). When social 
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class was added to the model, heavy drinking, passing out at least two times, or 
binge drinking did not lose their signifi cance (OR 1.9, 95% CI 1.21–2.86; 1.5, 95% 
CI 1.09–2.19; 1.7,95% CI 1.28–2.15, respectively), although social class itself did not 
have a signifi cant association with weekly bruxism. Binge drinking was strongly 
associated with weekly bruxism, and it retained its statistical signifi cance even after 
alcohol consumption and passing out were added to the model. In this model, 
however, alcohol consumption and passing out lost their statistical signifi cance 
when smoking status was accounted for, while binge drinking retained a signifi cant 
association with bruxism (OR 1.5; 95% CI 1.17–2.01). In addition, when multinomial 
logistic regression analyses were performed separately for non-smokers and all 
current smokers, binge drinking remained signifi cant in both groups (2.1 and 1.5, 
respectively), while other forms of alcohol use lost their statistical signifi cance in 
all current smokers. 
Figure 9. Proportions of weekly bruxism by alcohol use in men and women (Finnish Twin Cohort).
The risk of bruxism was further analysed using twin pairs discordant for alcohol 
use status to test whether the association exists even when the unmeasured familial 
and genetic factors are adjusted.  Alcohol intake raised the odds for any bruxism 
within the twin pairs in pairwise analyses and conditional logistic regressions, and 
the ORs increased in all twin pairs in association with more risky health habits. 
There were altogether 77 discordant MZ twin pairs where one twin experienced 
bruxism while the other did not and one reported binge drinking while the other 
did not. Of these, 45 were pairs where the twin with bruxism was also the one with 
binge drinking and 32 were pairs where the twin with bruxism was not the one 
with binge drinking (McNemar Chi-square test, p=0.14).  
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5.4.3. COFFEE CONSUMPTION AND BRUXISM
Weekly bruxism was more common among those consuming more than 8 cups of 
coffee daily than in those consuming less coffee (Figure 10). Moreover, the odds 
for weekly bruxism were higher among those consuming more than 8 cups of 
coffee daily (OR 1.9). This association held when smoking status was controlled 
(OR 1.4). Detailed ORs and CIs of coffee consumption in relation to weekly bruxism 
are shown in Figure 11. Multinomial logistic regression performed separately for 
non-smokers and all current smokers revealed that coffee consumption of more 
that 8 cups per day lost statistical signifi cance in non-smokers, while it remained 
signifi cant in all current smokers (OR 2.0, 95% CI 1.25–3.22). Pairwise analyses 
and condition logistic regression indicated that coffee consumption raised the odds 
for any bruxism within twin pairs.


































































































































This work rests on two large research projects based on population-wide Finnish 
twin cohorts. The fi rst part of this work (Studies I-II) derives from the FinnTwin16 
study on young adult twins and the second part (Studies III and IV) from the Finnish 
Twin Cohort study on middle-aged twins, which also included a substudy, the 
Nicotine Addiction Genetics Finland Study. The general aim here was to investigate 
the genetic and environmental factors affecting bruxism and the risk factors for 
bruxism. 
6.1. Main results and comparison with previous studies 
The results indicated that both genetic and environmental factors affect bruxism and 
psychoactive factors seemed to play an important role as risk factors for bruxism.
6.1.1. ROLE OF GENETIC AND ENVIRONMENTAL FACTORS IN BRUXISM
The fi rst aim of the study was to analyse the role of genetic and environmental factors 
in bruxism. The results indicate that genetic factors account for about half (52%) 
of the phenotypic variance in liability to bruxism, with no gender difference. This 
means that about half of the phenotypic difference is explained by genetic factors. 
A novel fi nding is that there was no gender difference in the liability to bruxism, 
meaning there is a common genetic background for bruxism in men and women, 
and no gender-specifi c genes or different proportions of genetic and environmental 
factors affect the liability. These fi ndings are important in the rather unknown 
aetiology of bruxism, shedding new light on it.
The earlier questionnaire-based studies or large-scale twin studies have also 
reported some genetic background for BRUXISM (Hublin et al. 1998, Lavigne, 
Manzini & Kato 2005, Lavigne et al. 2008). However, the earliest reports of the 
hereditary component of bruxism are derived from the 1960s and 1970s, when 
bruxism was thought to be mainly peripherally regulated. These studies were largely 
based on attrition patterns in dentition (Horowitz 1963, Lindqvist 1974), although 
a few studies were also based on self-reports of sleep bruxism (Abe & Shimakawa 
1966, Reding, Rubright & Zimmerman 1966). These earliest studies reported higher 
concordance rates for bruxism in monozygotic than dizygotic twins (Horowitz 1963, 
Lindqvist 1974), a signifi cant association between current bruxism and reported 
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bruxism in blood relatives (Reding, Rubright & Zimmerman 1966), and children 
whose parents experience sleep bruxism being more likely to suffer from bruxism 
than children whose parents do not experience bruxism (Abe & Shimakawa 1966). 
Regardless of the different approaches to determination of bruxism, these early 
fi ndings parallel the fi ndings in this study.
The results of this study are in line with the earlier fi ndings of Hublin et al. 
(1998), who reported a signifi cant effect of genetic factors, but also reported a gender 
difference in the liability to bruxismin an adult population (genetic factors explaining 
38.9% of the phenotypic variation in males and 53.2% in females). Although Hublin 
et al. (1998) also used data from Finnish twins, the twins in their study were older 
and were derived from a different cohort study (Finnish Twin Cohort study). But 
because they lack opposite-sex twin pairs, they could not perform a sex-limitation 
model, and thus, their results of a gender difference may differ from the results here. 
In any case, our results indicate that a common genetic background for bruxism 
exists in men and women. Interestingly, the best-fi tting model in their study was 
also the AE-model, indicating that the same genetic and environmental factors may 
affect individuals’ liability to bruxism throughout their life. The main conclusion 
based on our data together with the results from Hublin et al. (1998) is that the 
relative role of genetic factors in the liability to bruxism may be age-dependent. 
While there is no gender difference in young adults, there is likely to be a gender-
dependent genetic infl uence or a different relative magnitude of genetic effects by 
gender in middle-aged adults.
6.1.2. ROLE OF LEGAL PSYCHOACTIVE SUBSTANCES IN THE RISK OF BRUXISM
The general aim of the study was to examine the role of three legal psychoactive 
substances (tobacco, alcohol, and coffee) in the risk of bruxism. The results indicate 
that the legal psychoactive substances of tobacco, alcohol, and coffee seem to have 
independent effects on bruxism. Although the basic analyses were performed using 
twins as individuals, the twin approach strengthened the evidence of psychoactive 
substances as risk factors for bruxism. At the moment, no other studies using a 
twin approach to evaluate the association between psychoactive substances and 
bruxismexist. The use of twins enables the exclusion of the disturbing effect of shared 
genes between siblings (Boomsma, Busjahn & Peltonen 2002) because twin analyses 
adjust for familial factors shared by both co-twins. Thus, this twin approach provides 
additional adjustment even for unmeasured confounding factors. Therefore, regardless 
of the cross-sectional nature of this study, the results for discordant pairs suggest a 
causal association and analyses with genetically identical twin pairs provide further 
evidence that this association is independent of genetic background. 
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The present study focused on psychoactive substances while the effect of 
psychosocial factors was left out of the study. However, it is known that psychosocial 
factors, like stress or anxiety, and psychoactive substance use are often related 
(Koob 2003, World Health Organization 2004, Patton et al. 1998, Sonntag et al. 
2000). It is also unclear whether these factors have interactions with each other 
that affect their independent effects on bruxism. Previously, Ohayon et al. (2001) 
explored the association of bruxism with both psychosocial factors and the use of 
psychoactive substances in the same model. Further, in their adjusted model the 
use of psychoactive substances (tobacco, alcohol and coffee) and both high life stress 
and DSM-IV anxiety disorder diagnoses were all associated with bruxism although 
the odds decreased slightly. At the present study, social class was added into some 
analyses dealing with alcohol use. Other psychosocial factors, instead, were not 
investigated. According to the analyses, the adjustment of the model with social 
class did not affect the statistically signifi cance of the alcohol variables indicating 
that alcohol use affect bruxism regardless of social class status. In addition, social 
class itself did not associate with bruxism. Nevertheless, there is a lack of studies 
dealing with both psychosocial factors and psychoactive substances and their 
possible interactions and therefore there is a great need for further studies exploring 
the possible link between psychosocial factors and psychoactive substances in the 
etiology of bruxism. 
The mechanism underlying the relationship between psychoactive substances 
and bruxism is still unknown. The dopaminergic system (both hyper- and hypo-
dopaminergic states) has been linked to bruxism, but the evidence is weak (Lobbezoo 
et al. 1997, Lavigne et al. 2001, Lobbezoo, Van Der Zaag & Naeije 2006). In addition, 
some neurochemicals and their interactions with the dopaminergic system have 
been proposed to affect bruxism, but this evidence is also weak (Lobbezoo & 
Naeije 2001, Chen et al. 2005, Lobbezoo, Van Der Zaag & Naeije 2006). Because 
psychoactive substances affect the central nervous system and many of them also 
affect the dopaminergic system, their mechanism of action may arise from this 
link. However, the mechanism of action varies depending on the psychoactive 
substance, warranting more detailed neurological studies of the association between 
psychoactive substances and bruxism. Despite the fact that the detailed mechanism 
of the pathogenesis of bruxism is unknown and the specifi c mechanism of the 
actions of psychoactive substances in relation to bruxism remains unsolved, the 
present study indicates that bruxismis centrally regulated and may be linked to 
specifi c neurochemicals and systems of the brain. 
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6.1.2.1. Role of cumulative smoking and use of smokeless tobacco in the risk for 
bruxism and the association between nicotine dependence in ever-smokers and 
bruxism 
The second aim of the study was to examine the role of tobacco in the risk of 
bruxism. One of the main fi ndings was that both cumulative smoking and use of 
smokeless tobacco are important risk factors for bruxismin adults. They increased 
the odds strongly even when the other study variables and possible interactions 
were taken into account in both young adults and middle-aged adults using large-
scale epidemiological data sets. Also nicotine dependence seemed to be associated 
with increased odds for bruxismin middle-aged ever-smokers. 
Previously, only eight studies have investigated the role of smoking in bruxism 
and most of them have reported some degree of association between these (Lavigne 
et al. 1997, Molina et al. 2001, Ohayon, Li & Guilleminault 2001, Johansson et al. 
2004, Ahlberg et al. 2004, Ahlberg et al. 2005, Kato et al. 2012, Abe et al. 2012). 
Although smoking has been shown to be a risk factor for bruxism in these studies, 
the study approach has mainly been dichotomous, and study design, sample size, 
defi nition of smoking, assessment of bruxism, and control for covariates have varied 
greatly. However, most of these studies have concluded that smoking increases the 
odds for bruxism signifi cantly, with odds ratios varying from 1.35 to 2.4 (Lavigne et 
al. 1997, Molina et al. 2001, Ohayon, Li & Guilleminault 2001, Johansson et al. 2004, 
Ahlberg J. et al. 2004, Kato et al. 2012). Ahlberg et al. (2005) and Abe et al. (2012), 
by contrast, failed to fi nd a signifi cant association. In any case, our fi ndings related 
to smoking and nicotine intake and dependence are in line with most of the previous 
studies, and thus, improve the evidence that nicotine and smoking are important risk 
factors for bruxism. The approach of the present study also supports the signifi cance 
of nicotine itself, rather than other chemicals (such as carbon monoxide), as an 
instigator of the association because a signifi cant association was found with both 
forms of tobacco (smoked and smokeless), a clear dose-response relationship was 
shown, and nicotine dependence itself was associated with bruxism. 
6.1.2.2. Role of alcohol use and effects of different forms of alcohol use in the 
risk of bruxism 
The third aim of the study was to examine the role of alcohol in the risk of bruxism. 
The results indicated that alcohol is an important risk factor for bruxism. Also, 
according to the present fi ndings, the role of alcohol use is signifi cant even when 
smoking is taken into account. Multiple alcohol use patterns, especially heavy 
drinking, binge drinking, and frequently passing out due to excessive alcohol 
intake, seem to increase the odds for bruxism. Previous studies have shown varying 
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outcomes, with only some fi nding a signifi cant association between alcohol use and 
bruxism. Alcohol consumption has been estimated to raise the odds for bruxism 
from 1.5 to 1.8 (Ohayon, Li & Guilleminault 2001), depending on the dose. Overall, 
alcohol consumption seems to be more common among individuals with bruxism 
(Bellini et al. 2011). However, most studies have focused on alcohol quantities as 
the main measure of alcohol use and none of the previous studies have examined 
specifi c alcohol use patterns, and thus, our results provide new information about 
the nature of the relationship. 
This study had a broad approach to alcohol use, which allowed detailed evaluation 
of the impact of alcohol on bruxism. The results indicated that there is a dose-
response relationship between alcohol consumption and bruxism, and also binge 
drinking has specifi c effects on bruxism. The effect of binge drinking on bruxism may 
derive from the toxic effects of ethanol on the brain. Binge drinking and passing out 
due to excessive alcohol intake are common signs of alcohol dependence. Although 
we did not investigate alcohol dependence in this study, the results together with 
the results of nicotine dependence emphasize the need for further studies of the 
role of common psychoactive substance dependence in the genesis of bruxism. In 
addition, alcohol consumption is known to be strongly associated with smoking (Li et 
al. 2007), but none of the previous studies have examined the possible confounding 
effect of smoking on the association between alcohol use and bruxism in detail. We 
analysed the effect of an interaction variable smoking-alcohol and found that the 
effects of alcohol use are independent of smoking status, which further strengthens 
our results that alcohol is an important independent risk factor for bruxism.
6.1.2.3. Role of coffee consumption in the risk for bruxism 
The fourth aim of the study was to examine the role of coffee in the risk of bruxism. 
According to our results, coffee consumption of more than 8 cups per day increases 
the odds for bruxism almost two-fold. This, however, decreases to 1.4 when smoking 
status is taken into account. The results indicate that coffee as a psychoactive 
substance affects bruxism, probably in a dose-dependent manner. 
Although previous studies (Hartmann 1979, Hartmann et al. 1987, Molina et al. 
2001, Ohayon, Li & Guilleminault 2001, Bellini et al. 2011, Kato et al. 2012, Abe 
et al. 2012) have yielded varying results, the fi ndings here combined with those 
of Molina et al. (2001) and Ohayon et al. (2001) provide new information about 
the role of psychoactive substances in the risk for bruxism. Similar to alcohol use, 
coffee consumption is often related to smoking, which may affect the relationship 
between coffee and bruxism. We therefore added interaction variables to the 
analyses and found no interaction between coffee consumption and smoking. This 
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further indicates that substantial coffee consumption is an independent risk factor 
for bruxism.
6.2. Methodological considerations 
6.2.1. DATA AND DESIGN 
The data used in the present studies derive from unique large-scale twin cohort 
studies of Finnish adolescents and adults, namely the FinnTwin16 study and the 
Finnish Twin Cohort study, which have several strengths because of their twin 
design. The data are representative of the general Finnish population because 
all twin pairs of a given birth cohort around Finland were invited to participate. 
The data are also optimal for quantitative genetic modelling because of the twin 
design. In addition, the older cohort (Finnish Twin Cohort) does not differ in 
mortality risk from the general population, supporting the representativeness of 
the data (Kaprio 2013). The comprehensiveness of the questionnaire enabled the 
use of many variables as confounders. The fact that participants were also twins 
created the unique opportunity to analyze the role of genetic and environmental 
factors and further clarify the independent role of, for example, psychoactive 
substances in bruxism. The study was cross-sectional, although the large number 
of participants strengthens the value of our results remarkably. In addition, usually 
the causal nature of the association between an exposure (like the use of a given 
psychoactive substance) and a supposed outcome (like bruxism) is analysed in most 
epidemiological studies by examining potential confounding variables that may 
eliminate the observed association. If a multivariate model reveals no signifi cant 
confounders affecting the association being investigated, it supports the evidence of 
causality regardless of the cross-sectional nature of the data. Further, an alternative 
way to test possible causality is the use of discordant twin pairs, which tests whether 
the association exists even after adjustment for unmeasured familial and genetic 
factors. Therefore, the present twin study provides novel evidence for a possible 
causal link between psychoactive substance use and bruxism, and quantitative 
genetic modelling revealed important knowledge about the hereditability of oral 
health parameters and bruxism. Certainly, longitudinal analyses would add more 
specifi c information, and replication of the study in other twin data sets would be 
valuable. Prospective studies about the incidence of new cases of bruxism among 
users of psychoactive substances compared with non-users are also needed to 
strengthen knowledge about causality. 
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The measurement and categorization of study variables were performed in line 
with commonly used measures. In addition, in the genetic modelling the possible 
underestimation of the genetic component caused by a measurement error is 
incorporated into the environmental component as factors uncorrelating between 
twins. For example, the data of smoking is similar to the smoking behaviour of 
the Finnish population in other studies (Verkasalo et al. 1999, Suomen virallinen 
tilasto 2005, Helakorpi et al. 2008, Jääskeläinen 2011). This was previously studied 
by Verkasalo et al. (1999), who found that lung cancer incidence was an excellent 
indirect measure of smoking behaviour. Using the Finnish Twin Cohort linked 
to the Finnish Cancer Registry and the Central Population Register, the authors 
revealed that lung cancer incidence did not differ from that in the general population, 
indicating that the data used in part of our study as well are representative of 
the Finnish smoking population. However, according to the study of Broms et 
al. (2007), the heaviest smokers were somewhat underrepresented in the NAG 
study, likely indicating some underreporting. The situation is probably similar with 
alcohol intake. Especially heavy drinking and regular binge drinking are socially 
not acceptable in adults and may thus be underreported. Binge drinking is more 
common among students and young adults, whose reports may be therefore 
more reliable, if not indicating actual misuse of alcohol or alcohol dependency. 
Coffee consumption, by contrast, is not as likely to yield underreporting because 
it is a commonly accepted habit in Finland and a rather common practice in the 
adult population. The measurement and categorization of bruxism are somewhat 
problematic based on questionnaires alone; optimally, they would be based on sleep 
laboratory analyses. Nevertheless, this study yielded a similar prevalence to those 
previously found in Finland and elsewhere (Lavigne & Montplaisir 1994, Partinen 
& Hublin 2000, Lavigne, Manzini & Kato 2005). Because of the large number of 
participants, the high response rate, and the good representativeness of the general 
population, the use of a questionnaire here was justifi ed. Furthermore, the general 
fi nding of the overall prevalence of weekly bruxism has been that the occurrence 
is higher among young adults, and it gradually decreases in the elderly (Lavigne 
& Montplaisir 1994, Ohayon, Li & Guilleminault 2001). Because the prevalence in 
our data with both young adults and middle-aged adults was similar, it supports 
the use of the self-reporting methodological approach and ensures the overall 
representativeness of the data with respect to the general population. 
6.2.2. GENERALIZABILITY OF RESULTS 
The results of both the quantitative genetic modelling and the risk factor analyses can 
be generalized to the Finnish population of young and middle-aged adults because 
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the study samples were derived from the Finnish Twin Register with complete birth 
cohorts of twins born in Finland in the given years. The response rates were also 
high, improving the representativeness of the sample. Previous studies have found 
similar prevalence rates for the same variables in the Finnish population and in 
other countries, also supporting generalization of the results (Reding, Rubright & 
Zimmerman 1966, Glaros 1981, Lavigne & Montplaisir 1994, Hublin et al. 1998, 
Ohayon, Li & Guilleminault 2001, Lavigne, Manzini & Kato 2005, Suomen virallinen 
tilasto 2005, Jääskeläinen 2011, Jääskeläinen & Virtanen 2011). Generalization is 
further assisted by the variables being categorized in commonly used ways, thus 
allowing results to be compared and the study protocol to be repeated easily to 
obtain fi ndings for other populations. 
6.2.3. STRENGTHS AND LIMITATIONS 
The study was based on self-reports gathered by questionnaires in large cohorts 
of twins with high response rates. This supports the reliability and generalizability 
of the results, even though the information was gained from self-reports. The 
FinnTwin16 study collected data from almost 3000 twin individuals and Finnish 
Twin Cohort study from about 12 500 twin individuals; these are both very large 
samples compared with previous dental surveys on the subject matter. Although 
self-report is known to yield some biases (Stone et al. 2000) because the information 
is subjective not objective, it is widely used and accepted as an effi cient method in 
large population-based epidemiological surveys, where the gathering of information 
with exact laboratory or clinical methods from a vast number of participants would 
not otherwise be possible. Specifi c limitations with studying bruxismin conjunction 
with ICSD criteria-based diagnoses and standardized sleep laboratory settings 
are the high costs and logistic challenges (Lavigne, Rompre & Montplaisir 1996, 
Manfredini & Lobbezoo 2010), especially when the study population arrives from all 
over the country to broadly represent the general population. Generally, the major 
limitation with self-reports and questionnaires is, however, that some participants 
may answer in socially accepted ways, e.g. underreporting when asked about 
undesirable behaviours such as smoking and alcohol consumption. Participants 
may also give incorrect answers under distress (Turner et al. 2001) or if they are 
unsure of the situation, e.g. awareness of bruxism behaviour may arise only from a 
story told by a bed partner or by information given by the dentist based on clinical 
signs in the oral cavity and not an accurate clinical diagnosis. However, although 
the information on smoking behaviour is based on self-reports and no biochemical 
verifi cation was available for subjects, earlier population-based study in Finland 
from 1992 have indicated that current smokers do report their smoking status 
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very accurately (Vartiainen et al. 2002). Also, because of the large sample size, the 
prevalence of items studied correlated well with prevalence in earlier studies. The 
accuracy of answers is somewhat improved by the use of a categorized scale to 
facilitate estimation of dental variables, bruxism, and use of psychoactive substances. 
The major strength of the study was the twin design. Basically, in the analysis 
performed using twin data the method allows possible confounding effects of genes 
to be observed. Familial aggregation of a given trait may be due to genes or the 
environment shared by family members. For example, previous fi ndings together 
with our results illustrate that genetic components affect both smoking (Rose et 
al. 2009) and bruxism (Hublin et al. 1998). Earlier studies have also shown a clear 
association between smoking and bruxism (Lavigne et al. 1997, Molina et al. 2001, 
Ohayon, Li & Guilleminault 2001, Johansson et al. 2004, Ahlberg et al. 2004). 
This, however, may be due to the independent effect of smoking on bruxism or to 
underlying genetic effects common to both, i.e. two different phenotypes resulting 
from pleiotropic effects of genes. Notwithstanding many similarities to our results, 
Hublin et al. (1998) in their twin study on bruxism failed to fi nd any shared familial 
effect, which suggests that the association between smoking and bruxism cannot 
be explained by shared family effects common to these two phenotypes. Further, 
the analysis on discordant pairs taking the family background into account showed 
that an association between smoking and bruxism exists. However, to elucidate the 





7.1. Scientiﬁ c conclusions
The results of this questionnaire-based study using genetic modelling confi rm 
that genetic factors play an important role in the phenotypic variation of bruxism. 
However, the exact mechanism underlying these genetic factors remains unknown, 
and there is a need for further research to reveal whether a specifi c gene, a mechanism 
coded by a group of genes, or some indirect genetic effect underlies the development 
of bruxism.
This study, in addition, confi rms that legal psychoactive substances, mainly 
tobacco, alcohol, and coffee, are strongly associated with self-reported bruxism. 
It also gives evidence that the relationship is cumulative and dose-dependent 
in nature and that the psychoactive substances have independent roles as risk 
factors, independent also of shared genes. Nevertheless, further research is 
required to establish causality and also to examine whether there is a common 
genetic background for psychoactive substance use and bruxism; the latter can be 
ascertained with bivariate quantitative genetic modelling of twin data. The strong 
relationship between psychoactive substances and bruxism may give clues for future 
research into the exact mechanism underlying the genesis of bruxism and differing 
individual liability to bruxism.
7.2. Practical implications
These results have signifi cant clinical relevance in light of better understanding 
the risk factors affecting bruxism. Because curing bruxism is not possible based 
on current knowledge and the treatment of bruxism mostly consists of providing 
symptomatic relief and preventing complications, the practical implications of this 
study are mainly improving the clinical guidance and understanding of patients 
suffering from problems caused by bruxism. A clinically important fi nding is 
that psychoactive substance use may worsen bruxism. This creates a window of 
opportunity to offer general health advice and tobacco and alcohol interventions, 
possibly helping to reveal heavy substance use problems. Further, when there is 
suspicion about heavy psychoactive substance use, clinicians themselves can provide 
information and support, e.g. for the treatment of tobacco or alcohol dependence, 
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and help in the cessation process or refer the patient to an addiction specialist if 
needed. This may not only relieve the symptoms of bruxism, but most importantly, 
improve the patient’s general health. 
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